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MODULATION OF CARDIAC Kv CURRENTS BY Kvβ2 AND PYRIDINE 
NUCLEOTIDES 
Peter Joseph Kilfoil 
April 6, 2016 
Myocardial voltage-gated potassium (Kv) channels regulate the resting 
membrane potential and the repolarization phase of the action potential.  Members 
of the Kv1 and Kv4 family associate with ancillary subunits, such as the Kvβ 
proteins, that modify channel kinetics, gating and trafficking.  Previous 
investigation into the function of cardiac β subunits demonstrated that Kvβ1 
regulates Ito and IK,slow currents in the heart, but the role of Kvβ2 in the myocardium 
remains unknown. In heterologous expression systems, Kvβ2 increases surface 
expression of Kv1 channels, shifts the activation potential of Kv1 channels to more 
polarized voltages, and increases the inactivation of Kv1 channels.  Accordingly, 
the electrophysiological phenotype in Kvβ2-/- mice was examined to uncover its 
role.   
To investigate the effects of the loss of Kvβ2 on cardiac repolarization, we 
performed whole-cell electrophysiology on primary cardiac myocytes.  We found 
Kv current density was reduced and action potential duration prolonged in 
 vi 
myocytes lacking Kvβ2.  To isolate the molecular interactions by which Kvβ2 was 
affecting Kv currents, we show that Kvβ2 co-immunoprecipitates with Kv1.4 and 
Kv1.5 in heart lysates.  To measure if surface expression of these Kv channels 
was reduced with the loss of Kvβ2, we performed immunofluorescent confocal 
microscopy of isolated cardiac myocytes.   We found that the surface expression 
of Kv1.5 was reduced in Kvβ2-/- myocytes.  We also performed a membrane 
fractionation technique to demonstrate that the proportion of total cellular Kv1.5 at 
the membrane was reduced in Kvβ2-/-.  Together, these findings support our 
hypothesis that Kvβ2 plays a role in the generation of functional Kv currents in the 
myocardium by interacting with members of the Kv family.  
The pyridine nucleotides, NAD[P](H), are ubiquitous cofactors utilized as 
electron donors and acceptors by over 250 cellular oxidoreductases.  Work out of 
our laboratory has shown that the Kvβ proteins are functional enzymes of the aldo-
keto reductase family, that utilize NAD[P]H to catalyze the reduction of substrates.  
Furthermore, follow up work has shown that the redox status of bound pyridine 
nucleotide (PN) modifies the gating of Kvα-Kvβ channel complexes in 
heterologous expression systems. To examine a physiological role for PN in 
cardiac repolarization, whole-cell and single channel cardiac myocyte currents 
were recorded under the exposure to various PN redox states.  We found that the 
inactivation rates and open probabilities of Kv currents in isolated myocytes are 
sensitive to the redox status of PN, and that surface action potentials in an isolated 
heart model are prolonged by treatment with factors that increase intracellular 
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The ability to maintain and utilize ionic gradients across a semipermeable 
membrane is one of the defining characteristics of life on this planet.  It has been 
long believed that life on Earth originated in the sea as single-celled 
microorganisms that have acquired increasing complexity over the ages.  In time, 
the protocell somehow acquired the ability to maintain a high K+/low Na+ cytoplasm 
while bathed in the high Na+ of the oceans.  It should be noted that an alternative 
theory, in which the primordial cell developed terrestrially, has recently been 
proposed.1  In this new paradigm, evidence is presented supporting the argument 
that the birthplace of the first cell was in vapor-rich vents in inland geothermal 
systems.  There are two main driving evidences behind this hypothesis. First, the 
protocell would not have yet acquired the molecular machinery (i.e. active transport 
via energy dependent transmembrane pumps) to maintain a high intracellular K+ 
concentration in low [K+] seawater, implying that, initially, these cells’ cytoplasm 
was of similar composition to that of the aqueous environment from which they 
arose.  Second, cells across all three domains, archaea, bacteria, and eukarya, 
utilize trace elements such as zinc, manganese and phosphate in a variety of 
conserved cellular processes.  Seawater is low in Mn2+ and Zn2+, the latter being 
found at concentrations in the picomolar to femtomolar range.2  Analysis of the 
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composition of geothermal pools shows these inorganics to more closely match 
that of the cytoplasm.1  
While the origin of the primordial cell may be debated, it is evident that the 
increasing complexity of life has mirrored its ability to asymmetrically distribute 
inorganic ions (and later, organic molecules) across its semipermeable 
membranes, and more importantly, to utilize this gradient as a form of potential 
energy. The evolution of selectively permeable ion channels and transporters is 
key to higher forms of life. 
In the animal kingdom, maintenance of the steady-state ratio of K+/Na+ 
across the cell membrane via the sodium-potassium-ATPase accounts for up to 
4% of total energy expenditure in the myocardium3 and up to 20% in neurons.4  
Furthermore, myocardial Ca2+-ATPase (SERCA) utilizes up to 30% of cellular 
energy reserves.5  The appropriation of energy to maintaining various ionic 
gradients underscores their critical importance.     
 Eurkaryotic cells have the capacity to synthesize ATP by utilizing a proton 
gradient generated across the inner mitochondrial membrane, i.e. aerobic 
respiration.  One of the key evolutionary differences separating prokarya from 
eukarya is the presence of membrane-enclosed organelles, such as the 
mitochondria, and subsequently the ability to increase the efficiency of ATP 
conversion from energetic substrates.   
Aside from the universally conserved usage of the mitochondrial proton 
gradient to produce cellular energy (ATP), various specialized cell types utilize the 
electrochemical gradient generated by other asymmetrical ionic distributions to 
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perform unique functions.  Most cells maintain a negative cytoplasmic resting 
membrane potential relative to their surroundings, which is generated by three 
main processes: the Gibbs-Donnan equilibrium, the activity of the Na-K-ATPase 
pump, and the summation of chord conductances of ions to which the membrane 
is permeable, i.e. Na+, K+, and Cl-.  
The Gibbs-Donnan equilibrium states that the majority of intracellular 
membrane-impermeant ions have a negative charge at physiological pH, such as 
proteins, organic polyphosphates, amino acids and nucleic acids.  Since these 
species cannot reach a chemical equilibrium across the membrane, they impart a 
net negative charge to the cytoplasm.   These anions contribute approximately -10 
mV to the resting membrane potential relative to the extracellular fluid.   
      Excitable cells, such as neurons and myocytes, maintain a much more 
hyperpolarized resting membrane potential than other cell types, typically in the 
range of -40 to -90 mV.  The majority of this potential results from gradients of 
various inorganic ion concentrations across the plasma membrane.  Cytoplasmic 
concentrations of K+ (~150 mM), Na+ (~10 mM), and Cl- (5 mM) differ considerably 
from those typically found in the extracellular solution, K+ (5mM), Na+ (145 mM), 
Cl- (120 mM).  The equilibrium potentials for each ion can be calculated using the 
Nerst equation:  
Ein-Eout = - RT * 2.303 log ([X]in / [X]out) / zF 
where [X]in  and [X]out are the concentrations of ion X across a membrane, R is the 
ideal gas constant, T is the temperature in Kelvin, F is Faraday’s constant and z is 
the ion valence.  The equilibrium potential for Cl- (ECl) in skeletal muscle is 
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approximately -90 mV, near this tissue’s resting membrane potential, so the net 
movement of Cl- at resting membrane potential is near zero.  EK in skeletal muscle 
is about -100 mV, resulting in a small net movement of K+ ions out of the cell.  ENa 
is approximately +65 mV, thus both the electrical and concentration forces on Na+ 
drive it into the cell.   
 As described supra vide, a significant portion of a cell’s energy is expended 
by the Na-K-ATPase to maintain Na+ and K+ gradients against their 
electrochemical equilibria.  This pump moves 3 Na+ ions out of the cell for every 2 
K+ that moves in, causing a net positive charge to exit the cell, and is thus termed 
“electrogenic”.  In itself, this net movement of positive charge out of the cell is 
responsible for ~-5 mV of a neuron’s or skeletal and cardiac muscles’ resting 
membrane potential.  In other cell types, such as smooth muscle, it may contribute 
over -20 mV to the transmembrane voltage difference.  While its direct effect on 
membrane potential is not insignificant, its true indispensible function is the 
maintenance of the K+/Na+ gradient utilized by voltage-gated channels. 
 By far the greatest contribution to membrane potential in excitable cells is 
the utilization of passive diffusion of Na+ and K+ down their electrochemical 
gradients though variably conductive pores. The conductance of a membrane to 
an ion can be described as the sum of the conductance of various ion channels to 
which that ion is permeant. This relationship is described by the chord conductance 
equation: 
Em = (gK*Ek)/(gK + gNa + gCl) + (gNa*ENa)/(gK + gNa + gCl) +(gCl*ECl/(gK + gNa + gCl) 
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Where g is the conductance of the membrane to the noted ion and E is the 
equilibrium potential to the noted ion and Em is the equilibrium potential of the 
membrane.  As a membrane becomes more permeant to a particular ion, the 
membrane potential is driven toward the equilibrium potential of that ion.  In the 
cardiac myocyte and neuron, the relative steady-state gK+ is high, thus the resting 
membrane potential is near the equilibrium potential for K+. During the action 
potential, the relative gNa+ increases drastically and Na+ rushes into the cell, 
causing rapid depolarization to near ENa of approximately +65 mV.  Membrane 
potential is then restituted as gNa+ rapidly falls and gK+ increases, driving the cell 
back toward the EK of about -90 mV. It is the finely tuned activity of multiple families 
of voltage-gated ion channels that both maintain and make use of this form of 
potential energy to accomplish a wide range of functions in various electrically 
active cell types.        
 
The action potential 
An action potential is a rapid depolarization in membrane potential followed 
by a return to resting membrane potential.  The shape, duration and size of action 
potentials differ considerably between excitable tissues, reflective of the diverse 
populations of voltage-gated ion channels functionally expressed on a tissue and 
cell type-specific basis.  While virtually all mammalian cell types express some 
combination of voltage-gated ion channels, only cells in the nervous system, 
muscle (skeletal and cardiac) and some neuroendocrine cells exhibit classical 
action potential firing patterns.  These tissues exhibit what can be considered the 
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evolutionarily conserved purpose of the action potential: finely tuned management 
of intracellular calcium levels through the activation of voltage-dependent calcium 
channels.  Calcium is unique when compared to other ions in that its 
transmembrane concentration gradient is very large; basal cytosolic calcium 
concentration in most cells is on the order of 10-8 to 10-7 M, compared to 10-3 M in 
extracellular fluids.  Comparatively, intracellular and extracellular concentrations 
of both Na+ and K+ differ by 1 to 2 orders of magnitude.   
Cells expend a great deal of energy to maintain nanomolar [Ca2+]i, by 
actively transporting it out of the cell or into dedicated internal stores such as the 
sarcoplasmic reticulum.  This finely tuned management is necessary because 
calcium acts as a second messenger, coupling electrical activities with many 
cellular events. Disruption of calcium homeostasis has detrimental effects on cell 
physiology, and prolonged elevation of intracellular calcium levels is common to 
both pathological (necrotic) and programmed (apoptotic) cell death, as well as 
contractile dysfunction in muscle.       
In neurons, calcium entry through voltage-gated Ca2+ channels initiates 
synaptic transmission.  In this process, calcium-sensitive synaptotagmins in the 
presynaptic terminal are activated by the transient rise in calcium concentration.  
These secretory proteins transduce the chemical Ca2+ signal to the exocytotic 
machinery, causing neurotransmitter release. The synaptotagmins are common to 
most other Ca2+-regulated exocytotic processes, including hormone release from 
endocrine and neuroendocrine cells.   
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In muscle cells, calcium acts as a second messenger transducing cellular 
depolarization with contraction, a process known as excitation-contraction 
coupling.  Activation of sarcolemmal voltage-gated Ca2+ channels by 
depolarization results in the entry of calcium ions that further promote Ca2+ release 
through the ryanodine receptor from the sarcosplasmic reticulum.  The excitation-
contraction signaling terminates on the myofilament apparatus; calcium binds to 
one of 4 high affinity sites on troponin C, causing a conformational change that 
displaces tropomyosin from its actin binding sites.  This allows crossbridging 
between the actin and myosin filaments, resulting in the power stroke that is the 
functional hallmark of muscle tissue.   
Restitution of nanomolar cytosolic calcium levels is accomplished through 
active transport out of the cell through the plasma membrane Ca2+-ATPase 
(PMCA) and the Na+-Ca2+ exchanger (NCX) and into internal stores through the 
sarcoplasmic reticulum ATPase (SERCA).  In the mammalian myocardium, Ca2+ 
extrusion is dominated by SERCA (70-90%) and NCX (10-30%).6 
In order to turn off the stimuli of the excitation-contraction and exocytotic 
pathways, i.e. calcium entry through voltage-gated Ca2+ channels, the cell must 
repolarize to membrane potentials at which the open probability of these channels 
is negligible.  The preponderance of this repolarization is accomplished by the 
activation of the voltage-gated K+ channels.   
 
Voltage-gated K+ channels  
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The voltage-gated K+ channel (Kv) family represents one of the most 
diverse families of ion channels.  The products of these gene families have 6 
transmembrane spanning domains (S1-S6) and assemble tetramerically through 
association of an N-terminal tetramerization (T1) domain to form a central ion-
conducting pore.  Over 40 mammalian Kv channel α-subunits encoded by 11 gene 
families (Kv1-Kv11) have been identified to date. These proteins form channels 
that vary widely in their gating properties, kinetics, and pharmacology.  Even within 
gene families, different genes may encode for alpha subunits with vastly different 
properties (i.e. Kv1.4 and Kv1.5 generate rapidly-inactivating A-type currents and 
non-inactivating delayed rectifier currents, respectively).  Their functional diversity 
is further underscored by the fact that different alpha subunits of the same family 
may heterotetramerize in vivo, such as Kv1.2/Kv1.5 in vascular smooth muscle7 
and Kv1.3/Kv1.5 in T-lymphocytes.8  This produces functional channels with gating 
and pharmacological properties intermediate to that of homotetramers formed from 
their individual components. Furthermore, the gating and pharmacology of Kv 
channels is altered by ancillary beta subunits, which include Kcne, KChIP, and Kvβ 
family proteins.  The result is an impressive functional diversity that matches 
repolarization dynamics to a cell’s requirements.  The critical role of ancillary Kv 
channel subunits is demonstrated by the fact that mutations in these proteins have 
been linked to a various pathologies in both humans and animals, including cardiac 
arrhythmias, hypertension, epilepsy and learning deficits.9 10  
Not unexpectedly, mutations in Kv alpha subunits are also associated with 
a wide range of diseases.  Mutations in Kv1 family members cause ataxia,11  
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epilepsy,12 atrial arrhythmias,13-15 and olfactory deficits.16  Mutations in the Kv2 
family have been linked to reduced left ventricular mass17 and infantile epilepsy.18  
Kv3 mutations are associated with spinocerebellar ataxia and cognitive defects19  
and antibiotic-induced cardiac arrhythmia.20  A truncation in Kv4.2 has been linked 
to temporal lobe epilepsy.21  Genome wide association studies (GWAS) will 
undoubtedly uncover more genetic variants responsible for channelopathies 
afflicting various tissues and organs.   
 
Kv channel structure and function 
The first mammalian Kv structure resolved with x-ray crystolography 
brought great insight into the structure-function relationship of this channel 
family.22  In this work, Kv1.2 from Rattus norvegicus was determined to a resolution 
of 2.9 Å, elucidating the structures and mechanisms responsible for voltage 
sensing and electromechanical coupling involved in the opening of the ion-
conducting central pore. This study built upon structural descriptions of the 
prokaryotic K+ channels KcsA and KvAP, which elucidated the amino acid bases 
for the K+ selectivity filter (transmembrane segments S5 and S6), voltage sensing 
(transmembrane segments S1-S4) and central pore formation.23, 24   These works 
confirmed the tetrameric association of α-subunits, arranged in four-fold symmetry 
around the central axis forming the conduction pore (Figure 1.1).        
The selectivity filter is lined with carbonyl groups along a 12 Å segment of 
the S6 along the central pore.  These electronegative carbonyls coordinate with 
the cation and allow for the dehydration of K+ ions as they enter the central pore.  
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In the aqueous environment of the central pore, the K+ ion is resolvated and 
expelled into the extracellular space by electrostatic forces. A consensus 
sequence (Thr-Val-Gly-Try/Phe-Gly) in the selectivity filter is highly conserved 
throughout evolution and is present in almost all K+ channels.  The atomic radius 
of Na+ (0.96 Å) is smaller than that of K+ (1.33 Å), and thus cannot fully coordinate 
with the carbonyls of the selectivity filter, resulting in a 104-fold preference for the 
passage of K+ over Na+.   
The defining characteristic of Kv channels is their ability to sense and 
respond to changes in the transmembrane potential by altering their conductance. 
This process is dependent on four key arginine residues located on the S4 TM 
segment, loosely attached to the perimeter of the pore.  Upon changes in 
membrane transmembrane potential, the positively charged sidechains of these 4 
arginine residues from each of the 4 tetramerically arranged α-subunits transfer a 
total of 12-14 positive elemental charges across the membrane electric field from 
inside to outside.  The movement of these residues is transduced through the S4-
S5 linker helix to constrict or dilate the S6 helix that forms the inner part of the 
pore, thus allowing the voltage sensor to perform mechanical work on the pore.25  
This process comprises the activation gating of the voltage-gated ion channel, 
allowing for the conductance of K+ ions down their electrochemical gradient as the 
S6 region causes pore dilation (open state).  Membrane repolarization removes 
the electrical field effect on the voltage sensing domains, causing them to return 
to their initial position.  This movement is transduced via the same S4-S5 linker 
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helix to the S6 helix lining the pore returning it to its original constricted (closed) 
state in a process known as deactivation.     
In addition to activation and deactivation gating, voltage-gated ion channels 
can occupy a third gating state: the inactivated state.  Inactivation of a channel 
occurs when it enters into a stable, non-conducting conformational state from an 
activated state following membrane depolarization.  When in the inactivated state, 
a channel cannot conduct ions even if the transmembrane potential is favorable.  
Inactivation of an ion channel is accomplished through two mechanisms:  C-type 
inactivation and N-type inactivation (Figure 1.2). The C-type inactivation property 
was initially discovered when it was found that some voltage-gated channels 
displayed inactivation kinetics that were dependent upon splice variations in the C-
terminus.9  This mode of inactivation was also found to be independent of N-
terminal deletion.  C-type inactivation, which typically occurs on a slow time scale 
(10-1-100 s), involves extracellular conformational changes in the channel that 
result in the occlusion of the outer mouth of the ion-conducting central pore.26  Like 
activation, the return to the active channel state is voltage dependent.  This 
indicates that C-type inactivation is coupled to movement of the voltage sensing 
S4 domain during its initial response to membrane depolarization.  Recovery from 
inactivation occurs as the membrane is repolarized and the S4 domain returns to 
its original location, transducing a mechanical signal to open the pore mouth.  C-
type inactivation has been observed in all members of the Kv1 family. It also occurs 
in the related Kv4 and hERG (human ether-a-go-go related gene) family channels, 
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but with much faster recovery from inactivation kinetics, indicating a different 
molecular mechanism.27  
N-type inactivation, also known as ball and chain inactivation and fast 
inactivation, occurs with much more rapid kinetics (10-3 to 10-2 s) (Figure 1.3).  
Channels that display N-type inactivation contain an N-terminal domain of 
approximately 20 amino acids that are critical to this mechanism.  This N-terminus 
“ball” is followed by 60 amino acids in the “chain” domain.  Mutagenesis 
experiments on the N-terminus of the Kv1 drosophila homolog ShakerB 
demonstrated that the charge of the ball domain is critical to inactivation; 
increasing the positive charge in this region increases the rate of inactivation and 
conversely, decreasing the positive charge slows the rate of inactivation.28  Upon 
channel activation and pore opening, a negatively charged surface on the pore 
mouth is exposed.  This region electrostatically interacts with the positively 
charged residues in the N-terminus (the inactivation particle), rapidly occluding the 
conduction pore and placing the channel in an inactivated state.  Recovery from 
N-type inactivation to the closed but non-inactivated state requires the removal of 
the N-terminus inactivation particle from the pore.  The time course of recovery 
from inactivation is voltage dependent and sensitive to extracellular [K+], which 
indicates a mechanism in which a K+ ion displaces or destabilizes the interaction 
between the pore and the inactivation particle.29  
A Kv channel’s activation, inactivation, and recovery from activation kinetics 
are important in determining its contribution to cellular repolarization.  A rapidly 
activating and rapidly inactivating current such as the A-type currents generated 
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by Kv1.4 and Kv4.2 have a transient contribution to a cell’s repolarization, 
providing brief bursts of current early in the action potential that is not sustained.  
In the heart and neuron, these A-type currents are prominent and responsible for 
the early phase of repolarization.  Slowly activating but rapidly inactivating 
currents, such as those generated by hERG in the heart, provide repolarization 
capacity only later in the action potential.  Rapidly activating slowly inactivating 
currents, such as the cardiac Ikur (ultrarapid delayed rectifier potassium current), 
provide sustained repolarization capacity throughout the duration of the action 
potential.  Recovery from inactivation kinetics also dictates a channel’s contribution 
to repolarization on a use-dependent basis.  High-frequency action potential firing, 
as seen in the central nervous system, require rapid Kv channel recovery from 
inactivation to ensure their availability to participate in a series of repolarizing 
events.30  Conversely, prolonged Kv recovery from inactivation contributes to 
frequency dependent increases in excitability and changes in action potential 
shape.  This phenomena is well documented in the heart; the rate dependence of 
action potential duration and refractoriness in the ventricular endocardium differs 
from that of the epicardium.31  At the molecular level, the transient outward current, 
Ito, which dominates the early phase of cardiomyocyte repolarization, is generated 
by two different ion channels, Kv1.4 and Kv4.2.  These channels have significantly 
different rates of recovery from inactivation; Kv1.4 recovery occurs on the order of 
seconds32 while Kv4.2 recovers in milliseconds.33  Thus, the currents encoded by 
these channels are known as Ito,slow and Ito,fast, respectively.  The assymetrical 
distribution of these channels across the transmural gradient of the ventricular wall 
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is responsible for regional differences in repolarization and believed to be a 
mechanism by which to prevent re-entrant arrhythmias.34, 35  
 
Kv channel ancillary subunits 
When expressed in heterologous expression systems in vitro, Kvα- subunits 
form functional channels on their own.  In vivo, Kv channels are found to be 
coassembled with ancillary subunits in heteromultimeric protein complexes that 
modulate their gating kinetics (activation, inactivation, recovery from inactivation), 
pharmacology, and trafficking. Mutations in these subunits are associated with 
multiple pathologies in both human and animals, including hypertension, epilepsy, 
arrythmogenesis, hypothyroidism and periodic paralysis,10 which underscores their 
physiological importance.  
Four families of ancillary subunits are associated in vivo with members of 
the Kv superfamily:  KChIPs (Kv channel interacting proteins), KCNE (i.e. mink, 
minimal potassium channel subunit), DPPLs (dipeptidyl aminopeptidase-like 
proteins), and the Kvβs.  These subunits may associate with only one Kv 
subfamily, as demonstrated in KChIP preference for Kv4 channels, or with multiple 
Kv subfamilies, as with Kvβ proteins’ interaction with Kv1 and Kv4 members. 
Furthermore, their structures and mechanisms of physical interaction with the 
halochannel are distinct.  This is clearly demonstrated in the case of Kv4, which 
may associate in vivo with KChIP, DPPL, and Kvβ proteins simultaneously.  
Members of the same subunit family may have different or opposing effects on 
channel gating or trafficking.  Much of the information on subunit modulation of 
 15 
channel function has been garnered through in vitro experiments and is described 
at the single cell level.  Animal models harboring subunit point and deletion 
mutations have also given insight into the function of these proteins.  
 
KChIPs 
The K+ channel interacting proteins (KChIPs) associate with the cytosolic 
domain of Kv4 channels.  Kv4 channels are highly expressed in the ventricular 
myocardium, where they generate the cardiac transient outward current Ito,fast 36 
and in dendrites of central neurons, where they generate the A-type current.37  The 
association of various KChIPs with Kv4 produce channel complexes exhibiting a 
wide range of activation, inactivation and recovery from inactivation kinetics.38  
Alternative splicing of the products of the four known KChIP genes (KChIP1-4) 
makes it the most diverse family of Kv channel subunits.   
 The binding of KChIPs to the Kv4 N-terminus alters both the voltage-
dependence and time course of the Kv4 current in a manner that is dependent on 
both KChIP subunit and Kv4 isoform composition.  Different KChIPs also have 
profound and differential effects on current density, presumably through altering 
surface expression. For example, KChIP1 increases the rate of Kv4.1 inactivation 
but causes a 4-fold decrease in the rate of Kv4.2 inactivation.39  KChIP1 
depolarizes the voltage dependence of activation (V1,2-act) of Kv4.1 by 
approximately 10 mV but hyperpolarizes the Kv4.2 V1,2-act by up to -40 mV.  
Coexpression of KChIP1 with Kv4.2 causes a 15-fold decrease in expression 
whereas coexpression of KChIP2 with Kv4.2 causes a 55-fold increase in surface 
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expression.40 Clearly, the association of KChIPs with different Kv4 members 
produce channel complexes exhibiting a profound range of electrophysiological 
signatures.  
 
DPPLs   
The dipeptidyl aminopeptidase-like proteins (DPPLs) modify the effects of 
KChIPs on Kv channels.  Heterologous expression of Kv4 with various KChIPs did 
not fully reconstitute the kinetics of A-type currents recorded from primary neurons, 
despite strong evidence that they originated from Kv4.2.  Indeed, 
coimmunoprecipitation of Kv4 in rat brain membranes revealed an association with 
DPPX, a protein of then unknown function.41  Co-expression of this protein with 
Kv4.2 in Xenopus oocytes caused a large increase in current density by facilitating 
trafficking and surface expression. It also accelerated the rate of inactivation and 
recovery from inactivation. When the Kv4.2/KChIP2/DPPX complex was 
expressed, current properties better matched the A-type kinetics found in neurons 
and the Ito kinetics in the heart.42  
 
KCNEs 
The KCNE gene family encodes single-pass integral membrane proteins 
that associated with members of the Kv7 family (KCNQ) early in their maturation 
and assist in their trafficking and alter their gating.   KCNE1 interacts with Kv7.1 to 
slow its time course of activation, right-shift its current-voltage relationship, reduce 
inactivation and increase single channel conductance43 and increase its surface 
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expression.44  Together, Kv7.1 and KCNE1 form the slow delayed rectifier 
potassium current Iks, a prominent delayed rectifying current in the heart.45  Of the 
4 families of ancillary Kv subunits, KCNE probably has the most critical function in 
the heart; mutations in KCNE1 are associated with the life threatening long QT 
syndrome.46  Mutations in KCNE2-5 are also associated with other ventricular and 
atrial arrhythmias.10  Interestingly, KCNE proteins display promiscuous binding to 
many members of the Kv superfamily, including Kv1, Kv2, Kv3, Kv4, and Kv11 
(hERG).44  The interaction with hERG, which generates the delayed rectifier 
potassium current IKr, is of particular importance to the proper functioning of the 
heart.  hERG plays a critical role in cardiac repolarization due to multiple known 
mutations in this gene linked to arrhythmias47 and the variety of drugs known to 
interact with the hERG channel to cause QT interval prolongation.48  
 
The Kvβ subunits 
Structure of the Kvβ proteins 
The Kvβ protein was first discovered in rat brain membranes by 
chromatography when it co-eluted from a dendrotoxin 1 (DTX-1) affinity column.49  
The purified proteins were run on a gel and silver stained, showing 3 bands.  One 
band at 76-80 kDa, corresponded to the column target, the DTX-1-sensitive alpha 
subunit, which was known to be a member of the Kv1 channel family.  Two other 
bands at 35 kDa (determined to be a degradation product) and 38 kDa of unknown 
origin were also revealed.  The molecular weights of these proteins closely 
matched that of the products of the Drosophila A-type K+ channel, which seemed 
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to contain peptides of 70 and 35 kDa, and was cloned a year earlier.50  Together 
these studies gave the first evidences of the heteromultimeric α4β4 composition 
that functional Kv channels assume in vivo.        
The concept of auxiliary subunits modulating the electrophysiological 
properties of ion channels had already been described for Na+ 51 and Ca2+ 
channels,52 and established a precedent for the functionality of the newly 
discovered Kv β-subunit.  Furthermore, cloned DTX-1-sensitive channels were 
known to be responsible for the synaptic A-type current in rat brain neurons, yet 
expression of these and other related Kv1 clones in Xenopus oocytes produced 
current with strikingly different inactivation characteristics.9, 53  
Rettig and Pongs54 were the first to demonstrate that Xenopus oocyte co-
expression of a β-subunit (Kvβ1) with members of the Kv1 family converted the 
non-inactivating Kv1 current into a rapidly inactivating current, quantitatively similar 
to the neuronal A-type current (Figure 1.4).  In this study, Kvβ1 and Kvβ2 cDNA 
were cloned from the rat brain and their protein products compared; alignment 
showed a C-terminal sequence that was 85% identical and an N-terminal domain 
of 79 amino acids that were present in Kvβ1 but not Kvβ2.  Hydropathy analysis 
and N-glycosylation patters indicated that the Kvβ proteins were cytosolic.  
Alignment of the Kvβ1 N-terminus with the N-termini of rapidly inactivating Kv1.4 
and Kv3.4 demonstrated high homology in the “ball” region.  Electrophysiological 
assays demonstrated that Kvβ1 imparted rapid inactivation to the non-inactivating 
RCK1 (Kv1.1).  Furthermore, coexpression of Kvβ1 with an N-terminal truncation 
mutant of Kv1.4 lacking its ball and chain region restored rapid inactivation 
 19 
properties to the channel complex, which indicated that the Kvβ1 proteins can 
provide the inactivating ball in a manner analogous to the N-type inactivation of 
Kv1.4. Consistent with this model, Kvβ2, which has a shorter N-terminal domain, 
is not found to induce N-type inactivation in delayed rectifying channels, although 
when assembled with Kv1.5, Kvβ2 causes a -10 mV shift in the activation threshold 
and accelerates channel activation. Kvβ2 also has been shown to modestly 
accelerate inactivation of Kv1.4 currents.55  Kvβ3, which possesses an inactivating 
ball region with 90% sequence identity to that of Kvβ1 has been subsequently 
found to impart rapid inactivation to slowly inactivating Kv1.5 channels.56  
Follow up studies investigated the nature of the association of the Kvβ 
subunits with various members of the Kv family.  It was found that Kvβ1 and Kvβ2 
expressed in COS-1 cells associated with all known members of the Kv1 family 
with similar affinities but not with the Kv2 or Kv3 families.57  Kvβ1 and Kvβ2 also 
coimmunoprecipitated with Kv4.2.  The non-covalent nature of the α-β interaction 
was confirmed by noting the detergent sensitivity of the immunoprecipitation 
process, yet interaction was strong enough to withstand high salt treatment.58  
Interestingly, the interaction between Kvβ and Kv1 (dissociated by 0.2% SDS) is 
more detergent sensitive than that between Kvβ and Kv4 (not dissociated by 
<0.6% SDS).57  In Kv1 channels, the N-terminal contains a hydrophilic NAB (N-
terminal A and B box) region that is necessary for α-subunit tetramierization.59  This 
domain, the T1 tetramerization domain, also contains a structural motif 
FYE/QLGE/DEAM/L in Kv1.560 that is necessary for Kvβ1-mediated inactivation of 
the channel.61  NAB domains within the Kv1-Kv4 families share about 40% amino 
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acid identity59, 62; α-subunits of these different families do not tetramerize. NAB 
domains share about 70% within subfamilies, which is enough to allow for 
heterotetramerization.  The Kv4 α-subunits homology in this region with Kv1 is 
insufficient for Kvβ interaction; they associate with Kvβ by a distinct mechanism 
that is C-terminus but not N-terminus dependent.63  Thus, Kvβ utilize distinct 
molecular mechanisms to interface with these two families of Kv channels.   
 
Phosphorylation 
 The primary structures of Kvβ suggest the presence of 15 consensus 
phosphorylation sites: 1 for PKA, 10 for PKC, and 4 for casein kinase II.64   Protein 
kinase A phosphorylation of N-terminus serine 24 in Kvβ1.3 has been 
demonstrated to decrease its inactivation effect on Kv1.5 and thus to increase 
outward current.65  The effect of this phosphorylation event is unsurprising given 
its location—addition of negative charge at or near the inactivation ball inhibits its 
interaction with the open pore of the Kvα.  PKC-dependent phosphorylation of 
Kvβ1.2 using phorbol 12-myristate 13-acetate (PMA) decreases the current 
conducted by Kv1.5/Kvβ1.2 complexes by depolarizing the voltage dependence of 
activation.66  
Aside from the effects of on channel complex gating, phosphorylation also 
regulates export from the endoplasmic reticulum and cell surface trafficking.67   The 
association of Kvα and Kvβ subunits occurs during translation in the ER, with 
maturation of the complex into its α4β4 form completing before ER export.68, 69 The 
Kvβ proteins are known to increase surface expression of Kv1 channels (described 
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in more detail below). The positive membrane trafficking effect on Kv1.2 by Kvβ2 
is dependent on phosphorylation of α-subunit at Ser 440 and Ser 441.70  
Phosphorylation of Kvβ2 at Ser 9 and Ser 41 was also shown to be critical to the 
increase in Kv1.2 at the cell membrane.  Cycline-dependent kinase (Cdk) 
phosphorylation of Kvβ2 at Ser9 and Ser 31 regulates axonal targeting of Kv1 
channels in the hippocampus.71  These neurons have a highly localized distribution 
of Kv1.1 and Kv1.2 channels at the juxtaparonode, which is lost both by genetic 
knockout of Kvβ2 or Ser/Ala mutations at the phosphorylation sites.  The 
mechanism of this effect occurs through the microtubule plus end-tracking protein 
(EB1) domain of Kvβ2, phosphorylation at S9 and S31 by Cdk2 and Cdk5 disrupts 
its binding to EB1, promoting its dissociation from microtubules and insertion into 
the membrane.  In vivo, Kvβ2 is found in complex with the atypical protein kinase 
C zeta (PKC-ζ), connected by the scaffolding proteins PKC-ξ interacting proteins 
1 and 2 (ZIP1 and ZIP2).72  The purpose of PKC-ξ phosphorylation is not fully 
elucidated, but inhibition of PKC-ξ activity may play a role in the ceramide-
dependent inhibition of Kv currents in pulmonary artery smooth muscle.73  
 
The Kvβ proteins are functional enzymes 
Three human Kvβ genes undergo alternative splicing to form a total of 6 Kvβ 
proteins (amino acid length): Kvβ1.1 (401), Kvβ1.2  (408), Kvβ1.3 (419), Kvβ2.1 
(367), Kvβ2.2 (353) and Kvβ3 (404).  The Kvβ proteins are members of the aldo-
keto reductase (AKR) superfamily that includes 15 individual families of 
oxidoreductases involved in carbonyl metabolism. Members of individual families 
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share at least 40% sequence homology with each other and <40% homology with 
other AKRs. All AKRs share a (β/α)8 triosephosphateisomerase-barrel structural 
fold in which the active site is located at the C-terminus. These proteins do not 
contain a Rossmann fold, but they bind pyridine nucleotides with high affinity via  
unique AKR nucleotide binding domains (discussed below).    
The AKR nature of Kvβ proteins was first identified by the significant 
homology between the amino acid sequence of the Shaker β-subunit and proteins 
of the AKR superfamily.74  Amino acid alignments also showed that the AKR 
residues involved in cofactor binding are conserved in the Shaker β-subunit.75  In 
accordance with these predictions, our lab found that purified Kvβ proteins bind to 
pyridine nucleotides with high affinity (Kd values between 0.1 and 6 μmol/L).76  In 
vitro these proteins bind NADP(H) with higher affinity than NAD(H). However, the 
nature of the cofactor bound to Kvβ in vivo is unclear, because NAD(H) levels in 
excitable tissues are 2- to 7-fold higher than that of NADP(H); therefore, it is 
possible that the lower affinity of Kvβ for NAD(H) is offset by higher NAD(H) levels 
in the cell. Hence, the extent and the nature of the nucleotide bound to Kvβ in vivo 
may depend on the prevailing concentration of all 4 nucleotides in a cell. We 
believe that this might allow the Kvβ to respond to a wide range of metabolic 
conditions by being sensitive to changes in both NADP(H) and NAD(H) levels. 
To examine the functional effects of pyridine nucleotide binding, our group 
previously studied Kvβ1.3-mediated inactivation of Kv1.5 expressed in COS-7 
cells (Figure 1.5).77  Our lab found that oxidized nucleotides (NAD[P]+) prevent 
inactivation, whereas reduced nucleotides have no effect. These findings have 
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been corroborated and expanded by subsequent investigations, which have 
shown that NAD(P)+ removes the inactivation of Kv1.1 by Kvβ178  and Kv1.5 
inactivation by Kvβ3.79  NAD(P)+ also has been shown to prevent the Kvβ2-
mediated hyperpolarizing shift in Kv1.5 activation79 and the acceleration of Kv1.4 
current inactivation.80  The results of whole-cell patch-clamp have been 
substantiated by excised inside-out single-channel experiments in which it was 
found that the mean open time and the open probability of Kv1.5+Kvβ1.377 and 
Kv1.1+Kvβ178 currents are increased by adding NAD+ to the perfusate. The 
specificity of these interactions has been established by site-directed mutagenesis 
studies, which indicate that active site mutations that prevent nucleotide binding 
abolish the effects of NAD(P)+ on current inactivation.81 Additional mutagenesis 
and domain-deletion experiments have shown that oxidized nucleotides promote 
the binding of Kvβ N-terminus to the core of the protein and thereby remove 
inactivation by preventing the N-terminus from blocking the channel.82 This 
interaction also may be regulated by the cytosolic C-terminus of the membrane-
spanning channel protein. For instance, it has been reported that deletion of Kv1.5 
C-terminus prevents NAD(P)+-mediated removal of inactivation by Kvβ3.79  
Moreover, even though NAD(P)H does not affect Kv1.5 inactivation by Kvβ1.3,77  
it accelerates Kv1.5 inactivation by Kvβ379.  Collectively, these observations 
indicate that pyridine nucleotides bind directly to the Kvβ active site and that 
NAD(P)+ binding induces a specific conformational change that prevents Kvβ-





Kv1 currents in the myocardium and the cardiac action potential 
The coordinated contraction and relaxation of cardiac muscle is necessary 
for the efficient pumping of blood.  Synchronized contraction requires the rapid 
electrical activation of cardiac myocytes throughout the entire heart.  This is 
accomplished through very low resistance connections, the gap junction proteins,  
which connect adjacent myocytes at the intercalated disk.  These proteins form 
physical connections between cells that freely allow the passage of ions and  
other small molecules.  The electrical syncytium formed by these cytoplasmic 
connections allows the depolarizing wave to be rapidly transmitted across the 
heart.  
Action potential morphology differs considerably between species, but the 
mechanisms of depolarization and propagation are highly conserved; in all 
mammalian hearts, cardiac action potential upstroke (depolarization) is 
accomplished by the activation and subsequent inactivation of voltage-gated Na+ 
channels.  The substantial interspecies variation is attributed primarily to 
heterogeneous expression of Kv and L-type Ca2+ channels, which is reflected in 
the time course of myocardial repolarization (Figure 1.6). 
Repolarizing K+ currents can be broadly segregated into two categories, the 
transient outward currents, Ito, and the outwardly rectifying currents, IK.36  Within 
each category, multiple subclasses exist, which display distinct kinetic and 
pharmacological properties.  In the mouse heart, two transient outward currents 
 25 
can be distinguished, Ito,fast and Ito,slow, which vary in their recovery from inactivation 
and pharmacological properties.  The expression of these two currents also differs 
spatially; while Ito,fast can be recorded from all areas of the ventricular myocardium, 
including the interventricular septum, Ito,slow expression is restricted to the 
septum.83  Outwardly rectifying currents in the mouse myocardium are described 
by three currents with various kinetics, IK,slow1, IK,slow2, and Isustained (or Iss).83, 84  No 
regionally distinct expression profile has been determined for these outward 
rectifiers.  Inwardly rectifying K+ currents of the KIR class also play a role in human 
but not mouse cardiac repolarization and set the resting membrane potential of the 
cardiac myocyte in both species.36 
 
The molecular identities of mouse cardiac Kv currents 
The transient outward current Ito 
Kv1.4 was the first gene cloned from the mammalian heart that encoded a 
rapidly inactivating K+ current.85  The cDNA for this gene, called RHK1 at the time, 
was isolated from a rat heart library and revealed a deduced amino acid sequence 
displaying characteristics of the Shaker voltage-gated K+ channels recently cloned 
from Drosophila: six segments corresponding to transmembrane domains, a 
domain homologous to the S4 voltage-sensor domain and a leucine zipper domain 
found between S4 and S5.  Southern blot analysis demonstrated expression of this 
gene was restricted to the brain and heart, with an absence in smooth and skeletal 
muscle.  Expression of the cloned gene in Xenopus oocytes generated an A-type 
rapidly inactivating current with activation and inactivation time courses and 
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voltage dependences that were grossly similar to the Ito current recorded from rat 
cardiac myocytes. The time course of recovery from inactivation for the cloned 
RHK1 gene differed substantially from that of Ito. With the limited but growing 
understanding of the effects of ancillary Kv subunits, it was reasonably speculated 
that the oocyte expression system might have lacked a protein responsible for 
modifying the recovery rate of the channel. 
Shortly thereafter, Tamkum et al. cloned another set of K+ channel genes 
from rat heart and aorta cDNA libraries.86  Five channels were cloned, four of which 
(RK1-RK4) were identical or similar to other Kv1 genes identified previously.  The 
fifth, RK5, encoded a unique channel with a sequence homology to the Drosophila 
Shal family (now known to be homologous to the mammalian Kv4 family), and 
stood as the first report of Shal family channel expression in a mammalian tissue.  
cDNAs of this gene were expressed in Xenopus oocytes in subsequent work for 
electrophysiological characterization.87, 88  These studies showed that rat Shal 
gave rise to rapidly activating and rapidly inactivating voltage-gated K+ channels 
with voltage dependences of activation and inactivation similar to both neuronal A-
type K+ currents and cardiac Ito.  Slight differences in pharmacology and 
inactivation time course between the RK5/Shal4 and native Ito currents have since 
been attributed to differential KChIP subunit expression in the heart and brain.10 
Ensuing studies combining molecular and electrophysiological approaches 
to elucidated the contributions of Shaker RCK4 and Shal RK5 in generation of 
cardiac Ito. Early studies demonstrated that the kinetics of Ito varied across the 
ventricular wall and in different regions of the heart.  This was examined eloquently 
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by Backx et al., who demonstrated regionally restricted Kv1.4 and Kv4.2 protein 
expression and a transmurally graded protein expression of Kv4.2 in the rodent 
heart.89  The later finding was subsequently explained by differential transmural 
KChiP expression by the transcription factor Irx5.90  
Many evidences by several groups support that the cardiac transient 
outward current is actually two regionally-restricted currents, Ito,fast (Ito,f) and Ito,slow 
(Ito,s), attributable to Kv4 and Kv1.4 respectively.  In addition to their spatial 
distribution, the two transient outward currents in the mouse myocardium can be 
distinguished readily based on their pharmacology and rates of recovery from 
inactivation matching their molecular correlates.91   The Ito,f current displays a rapid 
recovery from steady state inactivation (on the order of 10s through hundreds of 
milliseconds) and is sensitive to the giant crab spider toxin Heteropoda toxin at 
nanomolar concentrations.  Pharmacologicial isolation of Ito,f using Heteropoda 
toxin (HpTx2) demonstrates that this current displays A-type rapid inactivation and 
activation at relatively polarized membrane potentials.83  Together, these provided 
more evidence that Kv4.2 is the molecular correlate of the Ito,f  current in mice. This 
finding was further substantiated by Marban et al., who suppressed rat ventricular 
Ito using viral infection of a dominant-negative truncated Kv4.2 construct.92  Follow 
up studies indicated that in larger animals, including humans and dog, Ito,f  is 
encoded by the closely related Kv4.3.93  The Ito,f  current is highly conserved in the 
mammalian heart, having been well characterized in human, dog, cat, rat and 
mouse ventricular myocytes.94 The Ito,slow current is predominantly found in the 
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septum of mice and atrium of humans, which mirrors the protein expression of 
Kv1.4.89, 95  
Although the physiological importance of cardiac Kv1.4 is not as defined as 
it is for Kv4.2, the relationship between the two appears to be of importance in 
disease.  Many experimental and genetic models of heart failure and hypertrophy 
cause a decrease in ventricular Ito current density.96  In humans, Kv4.3 is 
downregulated in heart failure.97  In diabetic animals, Kv4.2 message and protein 
is reduced while Kv1.4 transcript and protein is increased, mimicking the changes 
in Ito kinetics in diabetes.98-101  This so called “isoform switching” between Kv4.2 
and Kv1.4 in the diabetic heart is being investigated as a possible contribution to 
increased incidence of ventricular arrhythmias in diabetic patients.     
 
The outwardly rectifying currents IK,slow1 and IK,slow2 
Whereas the mouse and human generate their transient outward currents 
through Kv4.2/Kv4.3 and Kv1.4 channels, their generation of delayed rectifying 
currents occurs through distinct molecular mechanisms.  The human ventricular 
delayed rectifying currents are distinguishable as three components, IKur 
(IK(ultrarapid)),  IKr (IK(rapid)), and IKs (IK(slow)), which are categorized based on the their 
rate of activation.36  The inactivation of these currents is slow enough such that 
they play a significant role in repolarization throughout phase 3 of the human action 
potential (Figure 1.2).  IKr and IKs can be detected in human myocytes isolated from 
the ventricles while IKur is a completely atrial current in humans.  The α-subunits 
responsible for generating these currents has been established after years of 
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intensive research.  The molecular correlate of IKr is hERG (also known as Kv11.1), 
the product of the gene KCNH2.  The IKs current is generated by the KVLQT1 
channel (also known as Kv7.1), the product of human KCNQ1.  The IKur current is 
generated by Kv1.5, the product of the Shaker-related gene KCNA5.  These 
channels are of immense clinical importance as mutations in and inadvertent 
pharmacological interactions with these channels are responsible for a multitude 
of channelopathies, including Long QT syndrome, Short QT syndrome, Familial 
Atrial Fibrillation, torsades de pointes, and idiopathic lone atrial fibrillation.36  
While hERG and KVLQT1 are not expressed in the mouse heart, Kv1.5 is 
a predominant current in the mouse ventricle.102  Initial investigations into mouse 
ventricular Kv currents demonstrated a very slowly inactivating component, termed 
IK,slow, played a significant role in myocyte repolarization.  Pharmacological 
approaches at characterizing the channel responsible for this current revealed two 
distinct components.  One component was sensitive to micromolar concentrations 
of 4-aminopyridine (4-AP), strongly indicative of Kv1-family contribution.  The 
second component was 4-AP insensitive but sensitive to tetraethylammonium 
(TEA), suggesting Kv2 family involvement.  Transgenic mice were also generated 
to further identify the channels involved in the IK,slow current.  The targeted genetic 
replacement of Kv1.5 with a truncated Kv1.1 to created a functional Kv1.5 
knockout mouse removed the 4-AP sensitive component of IK,slow and increased 
the incidence of spontaneous and triggered arrhythmias and caused QT 
prolongation.102 A functional Kv2.1 knockout mouse was generated using a 
 30 
dominant negative mutant, Kv2.1-N216, which eliminated the TEA-sensitive 
component of IK,slow and increased action potential duration.103  
The properties of mouse IK,slow1 are indistinguishable from the IKur found in atrial 
myocytes from larger animals, including human,83, 104, 105 and it is now accepted 
that Kv1.5 encodes the human atrial IKur.  Indeed, Kv1.5 has become a target in 
the development of drugs to treat atrial arrhythmias.106, 107 Perhaps not 
unexpectedly, many of the anti-arrhythmic compounds develop against Kv1.5 have 
had off target affects on other ion channels,108 underscoring the structural and 
pharmacological similarities of the multiple Kv-family channels that play a role in 
cardiac repolarization. The development of Kv1.5-specific anti-arrhythmic agents 
remain a major focus of the pharmaceutical industry.107  Furthermore, the critical 
role of Kv1.5 in human atrial function is demonstrated in its remodeling in patients 
with chronic atrial fibrillation where its protein abundance is reduced by up to 






















Figure 1.1: Overall structure of the Kv1.2 tetramer.  viewed from the extracellular solution, 
shown as ribbons. Each of the four subunits is colored uniquely. The transmembrane helices 
S1 to S6 are labeled for the subunit colored in red. Each S4 helix (red, for example) is nearest 















Figure 1.2:  Models of N-type and C-type inactivation of K+ channels.  A) N-type 
inactivation is dependent on an N-terminal inactivation “ball” domain  B) C-type inactivation 
involves the closure of the extracellular mouth of the channel.  Adapted from Rasmusson RL 
et al. Circ Res. 1998;82:739-750 


















Figure 1.3:  C-type and N-type inactivating currents.  Outward currents elicited by a +50 
mV depolarizing pulse from a holding potential of -100mV.  Left: RCK1 (Kv1.1) lacks an N-
terminal inactivation domain and inactivates by a slow C-type mechanism.  Right:  RCK4 
(Kv1.4) has an N-terminal “ball” domain and rapdily inactivates upon channel opening.  


















Figure 1.4:  Kvβ1 imparts rapid N-type inactivation.  Coexpression of Kvβ1 converts the 
slowly inactivating RCK1 (Kv1.1) into a rapidly inactivating channel complex.  Adapted from 





Figure 1.5:  Model of physiological regulation of voltage-gated potassium (Kv) 
channel by pyridine nucleotides. A, Composite representation of the Kvα–Kvβ 
complex. The membrane-spanning domains of Kvα are shown in blue. The T1 domain, 
which docks with Kvβ, is shown in light blue. The N-terminus of Kvβ forms the 
inactivating ball and chain assembly. In the NADPH-bound state of the Kvβ subunit, the 
N-terminal domain of Kvβ inactivates the channel by plugging the internal opening of 
the ion-permeation pathway, resulting in N-type inactivation (right). Binding of NADP+ 
to Kvβ prevents inactivation. For clarity, only 2 of the 4 subunits of Kvα and β are shown. 
B, Schematic showing the regulation of channel function by NADPH. The 
noninactivated (open) state of the channel is stabilized by NADP+, whereas NADPH 
binding induces inactivation. The transition between the inactivated and noninactivated 
state of the channel is mediated either by pyridine nucleotide exchange or by catalytic 
turnover involving the substrate-dependent conversion of NADPH to NADP+. C, Effect 
of NAD+ on single channel Kv activity in inside-out patches recorded in COS-7 cells 
expressing Kvα1.5 and Kvβ1.3 before and after exposure to 1 mmol/L NAD+. Currents 
recorded in response to a +50-mV depolarizing pulse. Reprinted with permission from 
Am J Physiol Cell Physiol, Tipparaju et al.42D, Stereoview of a ribbon representation 
showing the side view of the channel complex containing the transmembrane (TM) 
domain, the T1 scaffolding, and the auxiliary β-subunits. The NADP+ cofactor bound to 
each β-subunit is shown as indicated.36 (Illustration: Ben Smith.)  Adapted from Kilfoil 





























Figure 1.6:  Action potentials and underlying ionic currents.  Adult human (left) and mouse 
(right) ventricular myocytes have diverse outward K+ currents while inward Na+ and Ca2+ currents 
are similar. The diversity of K+ currents results in distinct action potential repolarization shapes in 







DETAILED MATERIALS AND METHODS 
 
Immunoprecipitations and Western Blot Analysis 
Western blot analyses were performed on fractionated protein lysates 
prepared from whole heart, isolated ventricular cardiomyocytes, and whole brain 
tissue from adult (12 to 22 week) Kvβ2 WT and Kvβ2-/- mice to examine Kv1.4, 
Kv1.5, Kv4.2, Kvβ1 and Kvβ2 expression patterns. All antibodies used in this study 
are commercially available, have been previously tested for specificity and cross-
reactivity and have been shown to be subunit specific. For Western blot analyses, 
proteins were fractionated on SDS-PAGE gels (any-kD or 7.5%, BioRad), 
transferred to PVDF membranes followed by overnight incubation at 4°C with a 
(polyclonal or monoclonal) anti-Kvβ2 (K17/70, Neuromab, Davis, CA), anti-Kv1.4 
(K13/31, Neuromab), or anti-Kv1.5 (APC-004, Alomone, Jeruselum, Israel) 
antibody. Following thorough washing, the membranes were incubated with 
horseradish peroxidase-conjugated anti-mouse or anti-rabbit secondary 
antibodies. The membranes were again thoroughly washed to remove excess 
substrate and then bound antibodies were detected using luminescent horseradish 
peroxidase substrate (Pierce ECL/ECL Plus, Thermoscientific) and scanned on 
Typhoon.  
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For immunoprecipitations, 50 µL protein G-coated magnetic beads (Dynabeads 
Protein G, 10003D, Life Technologies) were incubated with rocking overnight at 
4°C with 10 µg of anti-Kvβ2 (K17/70), Kv1.4 (K13/31), Kv1.5 (APC-004) or Kv4.2 
(K57/1) antibody in 200 µL PBS plus 0.01% TWEEN-20 (to prevent bead 
aggregation). To decrease the signal from antibody heavy and light chains on 
Western blot, the antibodies were then cross-linked to the beads. This was 
achieved by first washing the beads twice each with 1 mL of sodium borate (50 
mM, pH 9.0) followed by 30 min incubation by rocking at room temperature with 1 
mL of 25 mM dimethyl pimelimidate made fresh in 50 mM sodium borate. After 
removing the supernatant, the beads were resuspended in 1 mL of ethanolamine 
and incubated by rocking for 2 hours at room temperature. The beads were then 
washed gently with 1 mL PBS plus 0.01% TWEEN-20 three times. Once cross-
linking was complete, lysates were incubated with the beads by rocking overnight 
at 4°C. The supernatant was removed and saved. The beads were resuspended 
in 1:5 SDS loading buffer with 150 mM DTT in PBS plus 0.01% TWEEN-20 and 
then heated at 70°C for 10 min. The supernatant was then removed and boiled at 
100°C for 10 min. The eluted sample was then fractionated and immunoblotted as 
described above. 
Differential centrifugation was used to prepare membrane-enriched fractions from 
heart lysates.  In this procedure, hearts were homogenized in chilled glass in cold 
lysis buffer containing (in mM): mannitol 225, sucrose 75, EGTA 0.1, Tris-HCl 30, 
pH 7.4.  Protease and phosphatase inhibitor cocktails (Sigma) were added at a 
1:100 concentration.  The lysate was centrifuged at 3000 RPM for 10 min to 
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remove cellular debris and unbroken cells.  The supernatant was removed and set 
aside on ice while the pellet was resuspended in lysis buffer and again 
homogenized.  The 3000RPM spin was repeated on this lysate and the 
supernatants were pooled.  The collected supernatants were then centrifuged at 
124,000g for 1 hour at 4° C.  The supernatant was removed and the pellet was 
resuspended in 200 μL of buffer containing (in mM): Tris 50, EDTA 1 and 2% 
sarkosyl.  The pellet was pipetted and the solution sonicated 5 times for 30 
seconds until completely dissolved. Protein content was then measured by Lowry’s 
method and separated by SDS PAGE.   
 
Electrophysiological Recordings 
Cardiomyocytes isolated from the mouse ventricles were used for 
electrophysiological recordings.  Whole-cell voltage-clamp and current-clamp 
experiments were performed within 12 hours of cell isolation at the temperatures 
noted using an Axopatch 200B patch-clamp amplifier (Axon Instruments, Foster 
City, CA). For voltage-clamp experiments, cells were patched using borosilicate 
glass pipettes (1B150F-4 and TW150F-4, World Precision Instruments, Sarasota, 
FL) pulled using a Sutter P-87 (Sutter Instrument, Novato, CA) to a resistance of 
2-4 MΩ when filled with a pipette solution containing (in mM): K-aspartate 100, KCl 
30, MgCl2 1, HEPES 5, EGTA 5, Mg-ATP 5, NaCl 5, pH adjusted to 7.2 with KOH. 
For current clamp experiments, pipette resistance was 7-10 MΩ when filled with 
the same solution. Cardiomyocytes were placed in a 0.25mL recording chamber 
(RC-26, Warner Instruments, Hamden, CT) and perfused with an external solution 
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containing (in mM): NaCl 135, MgCl2 1.1, CaCl2 1.8, KCl 5.4, HEPES 10, glucose 
5.5, pH 7.4 adjusted with NaOH. CdCl2 (0.3 mM) was added to the bath solution 
for voltage-clamp experiments.  In experiments done at near physiological 
temperature, perfusate heating was controlled using an inline heater (64-0103, 
Warner Instruments) and heated magnetic platform (PM-1, Warner Instruments), 
controlled by a bipolar dual automatic temperature controller (TC-344B, Warner 
Instruments).  Only quiescent, single, rod-shaped cardiomyocytes with clear 
striations were selected for recording. In voltage-clamp experiments, cells were 
held at -80 mV and depolarized for 5 sec to potentials from -100 mV to +50 mV in 
10 mV steps at 0.05 Hz.  In some experiments, cells were depolarized to a single 
potential of +50 mV from the same holding of -80 mV. All voltage clamp protocols 
were preceded by a 50 ms inactivating prepulse to -40 mV to eliminate Na+ 
currents.110 Whole-cell series resistances and capacitances were electronically 
compensated at least 80% to minimize voltage error.  Action potentials were 
evoked by the injection of a small, short lasting current (0.8-2 nA, 1-2 ms) at 1.0 
Hz.  Cells were paced for 30 seconds to reach steady state and the final 5 action 
potentials were averaged for analysis.        
 
Analysis of electrophysiological recordings 
Voltage-clamp data were analyzed using Clampfit 9 (Axon Instruments).  
Peak currents were defined as the maximal K+ current reached over the period of 
depolarization.  The amplitudes and inactivation time constants of outward currents 
were best-fit using tri-exponential curve fitting, which was performed in Clampfit 
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using the Levenberg-Merquot (SP) iterative technique.  Only fittings with a 
correlation ≥ 0.98 were used in analysis.  Peak and component amplitudes were 
normalized by cell capacitance and expressed in pA/pF. Cell membrane 
capacitance were calculated immediately upon reaching whole-cell configuration 
by Clampfit through integration of the transient seen in response to a +10 mV 
voltage step from holding.  Action potentials were analyzed using a custom written 
Visual Basic program in Microsoft Excel to calculate resting membrane potential, 
action potential amplitude, dV/dtmaz, and action potential durations at 20% 
(APD20), 50% (APD50) and 90% (APD90) repolarization. Action potentials 
recorded after 30 sec pacing at 1 Hz were used for comparison.        
 
Mice 
Male Kvβ2-/- mice as well as strain-matched WT mice were bred in house 
and maintained on a mixed C56BL/6 x 129/SvEv background.  The Kvβ2-/- mice 
were originally obtained from Dr. Geoffrey Murphy of the University of Michigan 
Department of Physiology and The Molecular & Behavioral Neurosciences 
Institute. All procedures were approved by the University of Louisville Institutional 
Animal Care and Use Committee, IACUC number 14047.  
 
Isolation of adult mouse cardiac myocytes 
Male mice 12-24 weeks of age were used for cardiac myocyte isolation.  
Twenty minutes prior to anesthetization, an intraperitoneal injection of heparin 
sodium salt (>350 USP units, H3149, Sigma Aldrich) was administered to prevent 
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blood clotting in the coronary vasculature upon excision of the heart.  Mice were 
anesthetized by an intraperitoneal injection of sodium pentobarbital (160mg/kg) 
and placed in a supine position with limbs restrained by tape.  Upon positive 
confirmation of full anesthesia by paw pinch, the heart was rapidly and gently 
removed by thoracotomy and placed in a 70mm petri dish containing ice-cold 
(~1°C) calcium-free phosphate buffer solution (Gibco, ThermoFisher Scientific).  
Any non-cardiac tissue attached to the heart was rapidly removed while the heart 
was submerged in PBS, and the aorta was identified.  Using microfine foreceps, 
the aorta was lifted onto a 22-gauge cannula attached to a modified Langendorff 
system and the heart was secured to the cannula using #4-0 surgical suture.  The 
heart was perfused in retrograde Langendorff mode with buffers maintained at 
37°C using a water-jacketed heat exchanger (Radnotti LLC, Monrovia CA) and 
negative feedback heated water bath and pump.  Upon canulation, the heart was 
perfused with Tyrode’s solution containing (in mM) NaHCO3 18, NaCl 126, KCl 4.4, 
MgCl2 1, HEPES 4, glucose 11, BDM 10, Taurine 30, pH 7.4) under a constant 
pressure of 70mm Hg. The perfusion of this first calcium-free buffer serves the 
purpose of removing all blood from the coronary vasculature as well as causing 
the dissociation of gap junctions which aids in myocyte isolation.  Perfusion of 
calcium-free Tyrode’s solution was no longer than 5 min to avoid a decline in 
myocyte health due to the “calcium paradox”, 111, 112 a phenomenon wherein 
reintroduction to physiological Ca2+ levels (1-3 mM) following perfusion of Ca2+-
free buffer causes rapid deterioration of cell quality and myocyte hypercontracture 
due to Ca2+ influx.   
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After 5 minutes, the perfusion solution was exchanged with an enzyme 
solution consisting of the above Tyrode’s solution with the addition of Liberase TH 
280μg/mL, CaCl2 25μM, endotoxin-free BSA 0.1%, DNAse (Roche) 15μg/mL, 
protease type XIV (Sigma Aldrich) 16.8μg/mL, pH 7.4 with NaOH.  The heart was 
digested for approximately 8-10 minutes and then inspected visually for proper 
digestion.  The ventricles were then cut off the cannula and the heart was placed 
in a 35 mm dish containing mincing solution at 37°C comprised of the above 
enzyme solution with the addition of BSA 9mg/mL.  In this buffer, any remaining 
vasculature or nonventricular tissues were quickly dissected away and the heart 
was minced using fine tip forceps until most large pieces of tissue were gone.  The 
tissue and cells were then gently triturated by aspirating the solution with a 
serological pipette several times.  The cell-containing solution was passed through 
a 100-mesh stainless steel filter to remove any underdigested tissue.  The filtered 
solution containing dissociated cardiac myocytes were then purified of damaged 
or calcium intolerant cells by reintroducing calcium in 5 steps of increasing 
concentration. Cardiac myocytes were allowed 10 minutes to pellet in 5 tubes 
containing 50 μM, 75 μM, 125 μM, 275 μM and 525 μM CaCl2.  Following this final 
stage, a small aliquot (10 μL) of suspended cells was transferred to a 
hemocytometer for counting and inspection of isolation quality.  Using this protocol, 
over 1 * 106 cardiac myocytes (>90 % rod shaped with long aspect ratio) are 
routinely obtained.   
  For electrophysiological experiments, the cardiac myocytes were then 
suspended in a cold (4°C), high K+ solution containing (in mM): K+-glutamate 100, 
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KCl 25, KH2PO4 10, MgSO4 1, glucose 22, EGTA 0.5, HEPES 5, pH 7.2 with KOH.  
Cells were stored in the refrigerator until study, at which time a small aliquot of 
suspended cells was transferred into the bath of the patch clamp microscope.   
For immunofluorescence imaging studies, the cardiac myocytes were fixed 
as follows.  Cells were allowed to pellet in a 15 mL test tube and any remaining 
buffer was aspirated.  The pellet was then resuspended in 2 mL of calcium-free 
PBS 4°C.  Cold paraformaldehyde (4% in PBS) was then slowly added to the 
suspension for a final concentration of 3% PFA and allowed to incubate for 15 min 
total.  The first 10 minutes of fixation was performed with gentle rocking, and during 
the final 5 minutes the tube was placed upright to allow the cells to pellet.  The 
fixed cardiac myocytes were washed 3 with 15 mL of cold PBS, allowing 15 
minutes during each wash to allow the cells to pellet at the bottom of the tube.  
Following the final wash step, the cells were suspended in 2 mL of PBS and stored 
at 4°C for up to 3 months.   
For protein and mRNA analysis, the pellet of cells was flash frozen in liquid 
N2 and stored at -80°C for later use.    
 
Cell Immunofluorescence  
For immunofluorescent studies, 3000-5000 fixed cardiac myocytes were 
diluted into approximately 100μL and adhered to poly-L-lysine-coated coverslips 
using a Cytospin 4 Cytocentrifuge (Thermo Scientific) at 300 RPM.  This produced 
an even distribution of cells without significant cell overlap and no disruption in 
morphology.   
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Cells were permeabilized by incubating in PBS containing 0.1% Triton X-100 for 
10 minutes.  The permeabilized myocytes were then washed in PBS three times 
for 5 min.  Blocking was performed by incubating the cells in 1% BSA, 22.5 mg/mL 
glycine in PBS T (PBS + 0.1% Tween 20) for 30 minutes.   
 Primary antibody incubation dilutions were determined empirically for each 
antibody.  Primary antibodies were diluted in 1% BSA in PBST and incubated for 
either 1 hour at room temperature or overnight at 4°C in a humidified chamber.  
Following primary antibody incubation, the cells were washed in PBS 3 times for 5 
minutes.   
 Secondary antibodies, anti-rabbit or anti-mouse Alexa 647 (ThermoFisher 
Scientific) were diluted in 1% BSA at a concentration of 1:2500.  Cells were 
incubated in the secondary antibody for 45 minutes at room temperature in an 
opaque box.  Cells were then washed again in PBS 3 times for 5 minutes.  
Coverslips were then quickly dunked into a beaker containing deionized water, as 
we have found this minimizes the presence of any salt crystals formed by 
evaporation.  Cells were counterstained with ProLong Antifade reagent containing 
4,6-diamidino-2-phenylindole (DAPI, ThermoFisher Scientific), covered with a 12 
mm coverslip and sealed using clear nail polish.  Cells were stored in a slide box 
at 4°C until analyzed.  Fluorescence was observed using a Nikon A1 confocal 





Transthoracic echocardiography was performed using the Vevo 770 
echocardiography platform. Mice were anesthetized using 2% isoflurane initially, 
and were maintained under anesthesia for the remainder of the experiment using 
1.5% isoflurane.  Body temperature was maintained at 37°C using an electronic 
rectal thermometer interfaced to a servo-controlled heating lamp.  
Electrocardiograms were recorded using leads attached to each limb.  Mice were 
placed supine on an examination board and depilatory cream was used to remove 
all hair on chest.  Two-dimensional imaging of the parasternal long axis was 
performed using a 707-B 30 MHz scan head at 100 frames per second.  Short axis 
images were also recorded by rotating the scan head.  Two-dimensional images 
were obtained every millimeter between the papillary muscles and the apex.  M-
mode images were constructed from 2-D images and were used to measure heart 
rate (HR), left ventricular inner diameter during diastole and systole (LVIDd and 
LVIDs, respectively).  These measures were used to calculate fractional shortening 
(FS) using the equation:  FS= [(LVIDd-LVIDs)/LVIDd] x 100%.  Ventricular 
volumetric indices (diastolic and systolic volumes) were calculated using 
Simpson’s rule of integration on the serially acquired short-axis images.  These 
were used to calculate stroke volume (SV) as SV=diastolic volume – systolic 
volume.  Ejection fraction (EF) was calculated as EF= (stroke volume/diastolic 
volume) 100%.  Cardiac output (CO) was calculated as: CO= SV * HR.     
 
Cardiac histology  
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Hearts were rapidly excised and mounted on a 22-gauge blunted needle 
cannula as with the cardiac myocyte isolation protocol and were retrogradely 
perfused with room temperature PBS for 3 minutes followed by 4% PFA in PBS 
for 15 minutes.  Hearts were then removed from the cannula, dissected of any non-
myocardial tissues, and sectioned in either the coronal, sagittal or axial axes using 
a Zivic Mouse Heart Slicer (Zivic Instruments, Pittsburgh, PA) and incubated 
overnight in 4% PFA.  The next morning, the heart sections were transferred to a 
beaker containing 70% ethanol for short-term storage. Heart sections were then 
processed and embedded in paraffin blocks for long term storage.  Paraffin-
embedded tissue sections were sliced at 4 μm and stained with H&E.  Images of 
mid-heart cross sections were made using a digital camera mounted to an 
Olympus microscope.   
  
Quantitative RT-PCR 
RNA was extracted from heart samples using the RNeasy mini kit (Qiagen). 
RNA concentration and purity was measured using the Nanodrop 1000A 
Spectrophotometer (Thermo Scientific).  The cDNA library was prepared using a 
Bio-Rad mycycler Thermocycler at 42°C for 60 min and 94°C for 5 min.  When not 
used immediately, cDNA samples were stored at -20°C.  Total cDNA were diluted 
20-fold using RNAse free water prior to use.  RT-qPCR was done using iTax 
Universal SYBR Green Supermix (Bio-Rad) on the Applied Biosystems 7900 HT 
Real-Time PCR system.  Primers for Kvα, Kvβ, and mGAPDH (internal control) 
were added to wells of a 384-well plate appropriately.  cDNAs for each RNA 
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sample were run in triplicate.  The RQ of each Kv channel subunit in each sample 
were calculated using the 2-ΔΔCt method by normalization to the internal standard 
mGAPDH.  Specific amplification was confirmed by visualizing melting curves for 
each sample for the presence of a single sharp peak.  
 
Statistics 
Data are reported as mean ± SEM.  Data were analyzed using GraphPad 
Prism and Microsoft Excel with paired or unpaired t-test with Bonferroni correction 
or ANOVA. For paired experiments where treatment values were normalized to 
initial values, the Wilcoxon matched pairs nonparametric test was used.  P-values 


















Kvβ2 MODULATES CARDIAC Kv CURRENTS AND REPOLARIZATION 
Introduction 
The voltage-gated potassium (Kv) channels are widely expressed 
throughout excitable tissues and are the primary mediators of repolarization in 
neurons and the cardiac myocyte.  In the heart, Kv channels regulate the resting 
membrane potential, the frequency of pacemaker and the shape and duration of 
the action potential.106   As a superfamily consisting of over 40 different members, 
they form one of the most diverse ion channel families both in form and function.  
Their functional diversity is further expanded through the interaction with ancillary 
subunits, such as the Kvβ proteins.  These cytoplasmic subunits, which bind to the 
intracellular domain of Kv1 and Kv4 family channels, can have profound effects on 
channel trafficking and membrane expression,63, 68, 113  subcellular localization,71, 
114  and channel gating and kinetics.54, 56, 115, 116  
Much of the information regarding the electrophysiological and catalytic 
functions of the Kvβ proteins has been gained through the use of heterologous 
expression systems.   While much of both in vivo and primary cell characterization 
have been performed in the central nervous system, some descriptions of the 
physiological function of Kvβ proteins in other tissues and organs do exist.  The 
loss of Kvβ1 in the heart has been demonstrated to alter the cardiac Kv currents 
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Ito,f and Ik,slow.117 Furthermore, antisense knock down of Kvβ2 has been 
demonstrated to reduce Kv conductance, hyperpolarize the conductance-voltage 
relationship (V1/2-act, the voltage at which half the channels in a cell are in an 
activated state), increase the time course of current activation (τact, a measure of 
the rate of current change) and increase action potential duration in Xenopus 
myocytes.118 Kvβ2-/- mice also have a strong strain-dependent neurological 
phenotype.  In mice on a C57BL/6 background, loss of Kvβ2 leads to deficits in 
memory and learning and causes occasional seizures.119  
Therefore, we designed the present study to address our hypothesis that 
Kvβ2 plays a role in ventricular repolarization through a contribution to the 
generation of cardiac Kv currents by its interaction with one or more unknown 
members of the Kv family.  To this end, we used an approach that included single 
cell patch clamp and organ-level (Langendorff perfused heart) electrophysiology, 
protein measurement by Western blotting, co-immunoprecipitation, and cellular 
immunofluorescence.  We also assayed cardiac function using echocardiography 
to determine if contractile function of the heart was altered.  Together, we aimed 
to determine the cardiac phenotype of mice bearing a targeted disruption of the 
Kvβ2 gene (Kvβ2-/-) vs. their WT littermates.   
 
Results 
Kvβ2 expression in the mouse ventricle 
Western blotting of whole-heart lysates was performed to confirm the 
presence of Kvβ2 protein in mouse ventricular lysates (Figure 3.1).  We also 
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performed immunoblotting to determine if the loss of Kvβ2 impacts the protein 
expression of Kvα and Kvβ subunits previously described to interact with Kvβ2 in 
other cell types (Figure 3.1).   Using whole-cell ventricular lysates, protein levels 
of Kv1.4, Kv1.5, and Kv4.2 were not significantly altered in ventricles from Kvβ2-/- 
mice (Figure 3.2). To confirm cardiac myocyte expression of Kvβ2, isolated cardiac 
myocytes were fixed with paraformaldehyde, permeabilized and stained with a 
monoclonal anti-Kvβ2 antibody and anti-mouse Alexa 647 secondary antibody.  
Cells were viewed under confocal microscopy and it was shown that the greatest 
fluorescent intensity was localized to the sarcolemma (Figure 3.3).   
 
Kvβ2 interacts with Kv1.4 and Kv1.5 in the mouse heart 
Biochemical and electrophysiological work using expression systems has 
previously established that Kvβ2 interacts with most members of the Kv110 and 
Kv457, 63, 120 families both physically and functionally. In the brain, Kvβ2 has been 
shown to associate with Kv1.1, Kv1.2, Kv1.4, Kv1.6121 and Kv4.3,63 with Kv1.3 in 
lymphocytes122 and Kv1.5 in pancreatic islets.123 Previous work demonstrated that 
Kvβ1 directly interacts with Kv4.2 and Kv4.3, but not Kv1.4 or Kv1.5 in the mouse 
heart.117  
To determine the in vivo binding partners of Kvβ2 in the mouse heart, a co-
immunoprecipitation approach using magnetic bead-bound monocolonal anti-
Kvβ2 antibody was utilized.   Western blot analysis of ventricular lysates showed 
that Kv1.4 and Kv1.5 coimmunoprecipitate with Kvβ2. (Figure 3.4).  No positive 
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co-immunoprecipitation was observed in lysates prepared from Kvβ2-/- hearts, 
supporting the specificity of the interaction.      
 
Loss of Kvβ2 decreases surface expression of Kv1.5 in ventricular cardiac 
myocytes 
In heterologous systems, co-expression of Kvβ proteins increases the 
membrane expression of Kv1 and Kv4 channels.10, 124 To determine the effect of 
Kvβ2 on surface expression of Kv1.4, Kv1.5 and Kv4.2 channels, we compared 
the abundance of these Kv channels on the surface of ventricular cardiac myocytes 
isolated from WT and Kvβ2-/- mice.  To this end, two techniques were utilized: 
sarcolemmal membrane fractionation using differential centrifugation and confocal 
microscopy of fixed isolated cardiac myocytes.     
Whereas the total Kv1.5 protein in Kvβ2-/- ventricles was slightly greater 
than in WT (Figure 3.1), the ratio of Kv1.5 in the membrane-enriched fraction to 
that in supernatant was significantly reduced in Kvβ2-/- ventricular lysates (Figure 
3.5); this result suggests a role for Kvβ2 in moving Kv1.5 to the sarcolemma. The 
efficacy of the membrane separation protocol was confirmed by comparing pan-
cadherin detection in the membrane (M) and cytosolic (S) fractions (Figure 3.5), 
suggesting that all sarcolemmal protein was contained in the membrane-enriched 
fraction.  Furthermore, in accordance with findings in the literature, the membrane 
bound Kv1.5 was found as a single band, whereas Kv1.5 from whole cell 
preparations typically runs at two bands of distinct molecular weights.  In support 
of this finding, isolated cardiac myocytes were fixed and stained with anti-Kv1.5 
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antibody and visualized under confocal microscopy.  Surface fluorescence of 
Kv1.5 was reduced in Kvβ2-/- cardiac myocytes compared to WT controls (Figure 
3.6).     Together, these findings indicate a role for Kvβ2 in the surface expression 
of Kv1.5 channels in the heart.   
 
Loss of Kvβ2 reduces outward Kv current in ventricular cardiac myocytes 
To investigate whether Kv currents in cardiac myocytes were altered due to 
loss of Kvβ2, whole-cell voltage clamp (Figure 3.7) was used to compare the 
magnitude and time course of currents elicited in response to 5s, +50mV 
depolarizing pulses.  Triexponential fitting was used to dissect currents into three 
components based upon inactivation time constants.105  Peak current density  
(Ipeak) was reduced in Kvβ2-/- (p < 0.05, Figure 3.8 A-C).  The magnitude of current 
associated with the most rapidly inactivating exponential component, previously 
described to be attributed to Ito, was reduced from 30.0+/- 4.6 pA/pF in WT to 15.8 
+/- 2.0 pA/pF in Kvβ2-/- (p<0.01 Figure 3.8 D).  The magnitude of intermediate and 
slowly inactivating currents were reduced but did not reach statistical significance 
(p=0.13 and p=0.054, respectively, Figure 3.8 E,F).  The inactivation time constant 
values associated with each exponential term were not different between groups 
(Table 1).  
 
Reduced Kv current magnitude results in delayed action potential 
repolarization 
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As Kv currents are the driving force for cardiac myocyte repolarization, we 
tested whether the reduced Kv current densities observed in voltage-clamp 
conditions manifested in prolonged action potential durations.  Action potential 
repolarization was quantified as the time required for a cell to return to 20, 50, and 
90% of its resting membrane potential (APD20, APD50, and APD90).  
Repolarization was slowed significantly at each APD, indicating a significant 
repolarization deficit in Kvβ2-/- myocytes (Figure 3.9 B).  Other action potential 
parameters including upstroke velocity (dV/dtmax), resting membrane potential 
(RMP), and action potential amplitude (APA) were unchanged, confirming that the 
changes caused by loss of Kvβ2 are specific to repolarization and not due to broad 
electrophysiological instability or cell health (Figure 3.10).  We found that action 
potential duration was similarly prolonged by a partial blockade of Kv1.5 with the 
Kv channel blocker 4-aminopyridine.  At the concentration used (100 μM), we 
expected approximately 30% inhibition of Kv1.5 (IC50 270 μM)10, similar to the 
reduction in peak Kv current observed under voltage clamp.  Prolongation of action 
potentials by 4-AP was qualitatively similar to that observed in the  Kvβ2-/- cells 
(Figure 3.9 C).    
 To further confirm a repolarization deficit in the Kvβ2-/- heart, we perfomed 
a second series of experiments using the ex vivo Langendorff perfused heart 
model. Monophasic action potentials were recorded from the epicardial surface of 
the left ventricle during spontaneous beating (Figure 3.11 A-C).  In agreement with 
the transmembrane action potentials recorded from single isolated cardiac 
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myocytes, action potentials were significantly prolonged at 20, 50, and 90% 
repolarization (Figure 3.11 D-F).  
 
Baseline cardiac function is unchanged in Kvβ2-/- hearts 
 To examine if the prolonged cardiac repolarization seen in Kvβ2-/- 
manifested in changes in contractile function, we performed transthoracic 
echocardiography.  All functional cardiac parameters, including stroke volume, 
ejection fraction and cardiac output were unchanged (Figure 3.12).    We did find 
through necropsy study that Kvβ2-/- mice have smaller hearts than age- and sex-
matched WT mice.  The heart weight to tibia length ratio in Kvβ2-/- is significantly 
lower in Kvβ2-/- compared to age-matched WT (6.2 ± 0.1 mg/mm vs 7.4 ± 0.3 
mg/mm respectively, p < 0.002, Figure 3.13 A). This difference resulted from 
differential development in the left ventricle (Figure 3.13 B) as right ventricular 
development (Figure 3.13 C) was not different between groups.  Some hearts were 
sectioned in the transverse plane and stained with hematoxylin and eosin to 
compare gross anatomy and to visualize left ventricular development (Figure 3.13 
D). This difference does not arise from changes in cardiac myocyte size, which 
was not different between groups as measured either by microscopy or cellular 
capacitance during electrophysiological experiments (Figure 3.14).  
 
Discussion 
The results of this study show that Kvβ2 plays a role in repolarization in the 
heart through enhancement of Kv current density.  We found that Kvβ2 protein is 
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expressed in the heart, specifically in the cardiac myocyte. We found that Kvβ2 
physically associates with Kv1.4 and Kv1.5 in vivo, and plays a role in the 
functional expression of Kv currents through enhanced Kv current density.  The 
significant reduction in peak current density in response to depolarization appears 
to be driven by a reduction in Ito, as the triexponential fitting model employed 
showed the largest reduction in the magnitude in the most rapidly inactivating 
component of the outward current. This is evidence to suggest a functional 
interaction of Kvβ2 with Kv4.2 or Kv1.4, channels it is known to both associate with 
and promote the surface trafficking of.  We attempted to co-immunoprecipitate 
Kv4.2 using the method that showed positive interaction with Kv1.4 and Kv1.5, but 
were not able to detect this protein in the immunoprecipitated material. This is not 
definitive evidence for a lack of interaction of Kv4.2 with Kvβ2 in the heart, but it 
suggests that the reduction in Kv current may be occurring by another mechanism.  
One interpretation of our results is that the observed reduction in surface 
expression of Kv1.5 in the Kvβ2-/- could be participating in the reduction of peak 
current.  Kv1.5, the molecular correlate of the human Ikur current is very rapidly 
activating; under voltage clamp conditions when the cell is depolarized to +50 mV, 
it almost instantaneously activates and contributes to the peak current density.  
This however does not explain a contribution to the rapidly inactivating component 
of the outward current. The most plausible explanation for the reduced rapidly 
inactivating current aside from an interaction of Kvβ2 with Kv4.2, which was not 
detected by Co-IP, is that Kvβ2 is interacting with Kv1.4 in the WT heart.  Indeed, 
we found positive co-immunoprecipitation with Kv1.4. The magnitude of the current 
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with an intermediate inactivation rate, IK,slow1 was reduced but not to a statistically 
significant level.  This could be a result of a limitation in the fitting algorithm used.  
Recent work published since the time of these experiments supports the notion 
that 5 sec depolarizations are not adequately long enough to fully resolve the three 
components of the murine Kv currents, Ito, IK,slow1 and IK,slow2 and that 
depolarizations lasting as long as 20 seconds may be required to accurately 
separate the magnitudes of each Kv current.125 (Liu J 189) Nevertheless, we 
interpret the findings of significantly reduced Kv current density, positive co-
immunoprecipitation with Kv1.4 and Kv1.5, and reduced trafficking of Kv1.5 to the 
sarcolemma as strong evidences of a critical role of Kvβ2 in the generation of 
repolarizing currents in the mouse heart.   
 The impact of the observed reduction in Kv current is clear; in both single 
cell current-clamp and monophasic action potential recordings, Kvβ2 hearts have 
a significantly reduced repolarization capacity.  Action potential durations are 
prolonged at all levels of repolarization, strongly indicating an effect on the rapidly 
activating components of the total cardiac Kv current, Ito and IK,slow1.  This is 
supportive of voltage clamp results and the observed interactions with Kv1.4 and 
Kv1.5, components of Ito and IK,slow1, respectively.  Further work is warranted to 
confirm whether Kvβ2 is interacting with Kv4.2 in the mouse heart.     
In addition to the effects that Kvβ2 appears to have on the functional 
expression of Kv channels, that is the enhancement of Kv channel abundance at 
the sarcolemma, the results can also be interpreted as evidence that the loss of 
Kvβ2 may affect the gating of Kv1.4 and Kv1.5 in the heart. While the voltage 
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clamp results do not show any significant differences in inactivation rates of the 
three Kv component currents, we did not specifically address changes in their 
voltage dependence of activation, V1/2-act.  Accurately measuring the V1/2-act of a 
singly expressed channel in a heterologous system is straightforward, doing so in 
a primary cell that contains many different currents is not.  We have not yet 
addressed this experimentally, in part due to the fact that the pharmacology of 
Kv1.5 inhibitors is lacking.  The Kv1.5 blockers commercially available are 
chemical blockers that are not as highly specific as peptide inhibitors (i.e. spider 
toxins like HpTx) available for other channels.  Inhibition of IK,slow1/Kv1.5 with 
channel blockers such as 4-AP and Psora-4 likely would not allow for the very 
precise inhibition necessary to allow for measurement of activation kinetics.  One 
potential compound to address this question does exist, diphenyl phosphine oxide 
(DPO-1), which blocks Kv1.5 in the sub micromolar range with an 8-fold specificity 
over Ito.  This may be addressed in future experiments as we further characterize 
the mechanism by which Kvβ2 modulates cardiac Kv currents.   
   































Figure 3.1:  Expression of Kvα and Kvβ proteins in the mouse ventricle.  
Whole heart lysates were separated by SDS PAGE and incubated with anti-
Kv4.2, Kv1.5,  Kvβ1.1, Kvβ1.2, Kvβ2 and KChIP2 antibodies..  Kvβ2 protein is 

























Figure 3.2:  Quantification of Western immunoblots.  Western 
blots from Figure 3.1 were quantified using ImageJ.  .  Detection of 











Figure 3.3:  Cellular localization of Kvβ2 by immunofluorescence.  
Confocal microscopic images showing fixed isolated cardiac myocytes from 
WT (left) and Kvβ2-/- (right) mice stained with anti-Kvβ2 primary antibody 















Figure 3.4:  Immunoprecipitation of Kv1.4 and Kv1.5 by Kvβ2. Lysates prepared 
from isolated adult ventricles were immunoprecipitated (IP) using monoclonal anti-
Kvβ2, antibody. Lysates before IP were also blotted with the same antibodies. Both 
Kv1.4 and Kv1.5 co-immunoprecipitate with Kvβ2 and are not detected in 














Figure 3.5:  Ratio of Kv1.5 in the sarcolemma to cytosol.   Top: A membrane 
preparation protocol was used to separate and enrich plasma membrane proteins.  The 
efficacy of the separation was confirmed by blotting for pan-cadherin, a protein exclusively 
found in the sarcolemma.  Center:  For each heart (4WT and 6KO), two lanes were 
loaded, one with the membrane fraction (left) and cytosolic fraction (right).  The band 
intensity of each pair was compared to find a membrane:cytosolic Kv1.5 ratio for that 
heart. Note: membrane bound Kv1.5 appears as a single band, cytosolic Kv1.5 appears 
as a double band, both bands were included.  Bottom:  Quantification of the group 












































Figure 3.6:  Cellular localization of Kv1.5. Isolated cardiac myocytes were stained with 
an extracelluar epitope anti-Kv1.5 antibody with secondary Alexa647 staining and viewed 
under confocal microscopy.  Relative to WT, Kvβ2-/- showed reduced surface Kv1.5 


























Figure 3.7:  Isolated ventricular cardiac myocyte being recorded under 






























Figure 3.8:  Kv currents in isolated cardiac myocytes.  Representative outward 
current traces recorded from WT (A) and Kvβ2-/- (B) ventricular cardiac myocytes in 
response to a family of 5s depolarizing pulses from -90 to +60 mV (Δ=10mV) from a 
holding potential of -80mV.  Peak outward current density in response to +50 mV was 
significantly reduced (C).  Tri-exponential fitting of current responses to a 5s 50mV 
depolarizing pulse was used to deconvolve individual currents based on inactivation 
rates (D-F).  The magnitude of the rapidly inactivating current was significantly 

















































Figure 3.9:  Action potentials in ventricular cardiac myocytes.  A. 
Representative action potentials recorded from ventricular cardiomyocytes isolated 
from WT and Kvβ2-/- mice.  B. Transmembrane action potentials of right ventricular 
cardiac myocytes were prologned at APD20, APD50, and APD90.  C.  Partial 
blockade of Kv1 currents using 4-AP (100 uM) similarly prolonged action potential 













Figure 3.10 Non-repolarization indices of electrophysiological function.  Non-
repolarization indexes of cardiomyocyte function in Kvβ2-/- cells, including A. dV/dtmax , B. 



























Figure 3.11:  Surface action potentials.  Monophasic action potentials were 
recorded from electrodes placed on the left ventricular epicardial surface of 
Langendorff perfused hearts. Representative action potentials recorded from WT 
(A) and Kvβ2-/- (B), overlayed (C).  B.  Action potential durations at APD20 (D),  
APD50 (E), and APD90 (F) were significantly prolonged in Kvβ2-/- . n=5 mice WT 
and 6 mice Kvβ2-/-  *: p<0.05. Horizontal cale bar = 10ms.  Vertical scale bar = 20 
mV. These experiments were performed in collaboration with Dr. Srinivas Tipparaju 
and Dr. Kalyan Chapalamadugu at the University of South Florida Department of 


























Figure 3.12:  Baseline cardiac function.  Echocardiography was used to measure 
stroke volume, ejection fraction and cardiac output.  These functional values were similar 














Figure 3.13:  Cardiac anatomy. A. Heart weight normalized to tibia length in WT and Kvβ2-
/- mice.  B.  Left ventricular weight normalized to tibia length in WT and Kvβ2-/- animals.  C.  
Right ventricular mass was not reduced.  D. Transverse sections of hearts were stained 
with H&E stained transverse sections of hearts from WT and Kvβ2-/- animals. E.  Hearts 



























Figure 3.14:  Cardiac myocyte size in WT and Kvβ2-/- mice.  A. Cardiomyocyte 
length was measured under microscopy.  B.  Cardiomyocyte size was measured 
using capacitance during voltage-clamp experiments.  Over 50 cells from each 









Faced with a limited oxygen supply during ischemia, the oxidation of NADH 
by the mitochondrial electron transport chain complexes is inhibited, causing a rise 
in cytosolic NADH levels.  As a ubiquitous electron shuttling cofactor, changes in 
the NAD+/NADH ratio have widespread effects on the cell, including altering the 
activity of various enzymes involved in intermediate metabolism.  In the healthy 
heart, the ratio of NAD+/NADH remain generally constant as they are constantly 
recycled through various metabolic enzymes.  In the ischemic heart, this 
equilibrium is disturbed by the lack of oxygen, and the reduced NAD+ reserve is 
reflected in the inhibition of various dehydrogenases involved in energy 
metabolism.126  The accumulation of glycolytic byproducts NADH, lactate, and H+ 
may result in irreversible damage to the myocardium during ischemia.127  
The redox status of the pyridine nucleotide bound to Kvβ is known to alter 
the electrophysiological phenotype of the Kv channel complex (vide supra). 
Nucleotides in the reduced state, NAD(P)H, allow the rapid inactivation of the Kv 
channel by allowing free movement of the N-terminal inactivation domain of Kvβ1 
and Kvβ3 containing complexes.  Conversely, a bound nucleotide in the oxidized 
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state, NAD(P)+, inhibits N-type inactivation by restraining the N-terminus of Kvβ1 
and Kvβ3, preventing its access to the pore.82  Furthermore, in the presence of a 
bound oxidized nucleotide, the hyperpolarizing effect of Kvβ2 on Kv1.5 is lost, and 
the channel complex displays a V1/2-act not significantly different than that of Kv1.5 
alone, an effect that is likely conserved for all Kv1.5-Kvβ interactions.79   We 
therefore propose that Kvβ channel complexes may provide a mechanism linking 
cardiac metabolism with repolarization, which may be of particular importance 
during myocardial ischemia. 
The Kvβ proteins are members of the aldo-keto reductase (AKR) 
superfamily119, 128 and are functional oxidoreductases that utilize pyridine 
nucleotides, NAD[P](H),  for the reduction of a wide range of carbonyl substrates.80, 
129, 130  Accordingly, the Kvβ proteins bind pyridine nucleotides with high affinity, 
with Kd values in the low micromolar range.76, 81  
The redox status of the bound pyridine nucleotide confers profound electro-
physiological effects on the Kvα-Kvβ channel complex (Figure 1.5).  Studies in 
heterologous expression systems have demonstrated that oxidized nucleotides, 
NAD[P]+, prevent Kvβ1.3-mediated inactivation of Kv1.5.77  These studies have 
been expanded to include other Kvα-Kvβ arrangments,78-80  further elucidating how 
Kvβ-mediated modulation of Kv1 gating is dependent on the reduction state of the 
bound pyridine nucleotide.  The Kvβ2 protein product is shorter than Kvβ1 and 
Kvβ3, lacking the N-terminal domain responsible for rapidly inactivating Kv1 
channels.  NAD(P)+ has been shown to prevent the Kvβ2-mediated 
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hyperpolarizing shift in Kv1.5 activation voltage79 and acceleration of Kv1.4 
inactivation rate.80  
We therefore designed experiments to test our hypothesis that the cytosolic 
redox ratio of pyridine nucleotide affects cardiomyocyte excitability through the 
modulation of outward Kv currents.  We tested this using whole-cell voltage clamp, 
perforated-patch current clamp, excised-patch single channel patch clamp 
electrophysiology and Langendorff monophasic action potential recordings.    
 
Results 
Cardiac Kv current are differentially altered by pyridine nucleotide redox 
ratios 
In heterologous systems, the coexpression of Kv1 and Kvβ subunits 
generate Kv currents whose inactivation rates are modulated by pyridine 
nucleotides.54, 77, 80  To explore whether native cardiac Kv currents are sensitive to 
such changes, ventricular cardiac myocytes were patched in whole-cell 
configuration using pipette solutions chosen to represent normoxic and hypoxic 
cytosolic conditions (Figure 4.1).    Upon reaching whole-cell configuration, series 
resistance was compensated > 80% and pipette solution was allowed 5 min to 
dialyze with the cytoplasm before running voltage clamp protocols.  Outward 
currents were elicited with a +50 mV, 5 sec depolarization and fit triexponentially 
offline. We found that the inactivation rate of Kv currents was significantly 
accelerated under hypoxic compared to normoxic pipette conditions.  The time 
constants associated with the intermediately and slowly inactivating Kv currents, 
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IK,slow1 and IK,slow2 were reduced in cardiac myocytes patched with hypoxic internal 
solution than normoxic internal solution (Figure 4.1).  A comparison of all 
calculated values is found in Table 2.  Most notably, the intermediate tau value, 
attributable to the cardiac current Ik, slow1, was reduced from 189 +/- 6 ms  to 145 
+/- 11 ms in myocytes patched with pipette solution containing high NADH (Figure 
4.1).  It has been previously proposed that the  Ik,slow1 current is encoded by Kv1.5, 
which above we demonstrate to associate with Kvβ2.  
 
Langendorff perfusion with lactate increases cellular NADH concentration 
and slows cardiac repolarization 
 We utilized a model developed by Dudley et al131 to manipulate cytosolic 
NADH/NAD+ ratios.  In these experiments, sodium lactate and sodium pyruvate 
were added to the perfusion buffer to drive the lactate dehydrogenase reaction in 
the desired direction (Scheme 4.1).  In a preliminary experiment, hearts from both 
WT and Kvβ2-/- were perfused with Tyrode’s buffer containing 20 mM lactate for 
20 minutes and then frozen for measurement of cellular NADH content.  It was 
found that in both genotypes lactate perfusion significantly increased NADH levels 
(Figure 4.2).   
 In electrophysiological experiments, Langendorff hearts were allowed to 
beat spontaneously during perfusion and monophasic action potentials were 
recorded from the left ventricular epicardial surface.  It was found that action 
potential durations were prolonged following 20 minutes of perfusion with lactate 
20 mM as compared to each heart’s control values.  Action potential duration was 
 78 
increased significantly at 20%, 50%, and 90% repolarization in WT hearts, p<0.05, 
(Figure 4.3 A,B).  Action potential durations were not different from control values 
in Kvβ2-/- hearts (Figure 4.3 C, D). In a separate series of experiments, surface 
action potentials were recorded from WT hearts perfused with 20 mM lactate for 
20 min followed by 20 mM pyruvate for 20 min.  In these experiments, pyruvate 
perfusion caused APD90 to shorten toward their control values, presumably by 
restoring intracellular NAD+ levels (Figure 4.4).  
 
Action potentials recorded in perforated patch mode are prolonged by 
lactate perfusion 
We used current clamp to measure single cell action potentials in WT 
cardiac myocytes perfused with 10 mM lactate in Tyrode’s perfusion buffer.  The 
perforated patch configuration using Amphotericin B (250 μg/ml) was utilized 
because the pores formed by this perforating agent are sufficiently small to prevent 
the passage of any molecule larger than monovalent ions.  This allowed lactate to 
drive an intracellular increase in NADH without it dialyzing out of the cell into the 
pipette as it would in the whole-cell configuration.  Action potentials were elicited 
via small current injections of 0.8-1.0 nA lasting 2 ms at a frequency of 1 Hz.  Action 
potential durations following approximately 8 minutes of lactate superfusion were 
normalized to control values in the same cell. We found that APD50 was 
significantly increased during this treatment while APD20 and APD90 trended 
toward prolongation as well (Figure 4.5 B).  Action potential amplitude, resting 
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membrane potential and upstroke velocity, dV/dt were not affected by the 
treatment with lactate (Figure 4.5 C).    
 
Single channel Kv activity was altered by perfusion with 1 mM NADH 
 To directly test the effect of NADH on Kv channel activity, single channel 
activity was measured in inside-out patches pulled from freshly isolated cardiac 
myocytes.  Upon successfully obtaining an inside-out configuration, the membrane 
patch was perfused for at least 4 minutes with a minimal buffer containing 140 mM 
KCl, 10 mM HEPES and 1 mM HEDTA.  Pipette internal solution was symmetrical.  
The minimal composition of the buffer eliminated contamination with other cationic 
currents.  Chloride channel activity was ruled out based on single channel 
conductance values.  Patches were subjected to 4.5 s, +30 mV pulses at a 
frequency of 0.05 Hz.  Single channel activity was quantified as the percentage of 
time the patch stayed in the open and closed states during each sweep. In one 
representative experiment, the probability of the channel in the closed state 
increased 10-fold upon addition of 1 mM NADH to the perfusate (Figure 4.6 A, B).  
A marked increase in channel closure was seen almost immediately upon 
perfusion of NADH (Figure 4.6 C).             
 
Discussion 
We have demonstrated by multiple electrophysiological modalities that 
cardiac Kv conductance can be modulated by altering the pyridine nucleotide 
redox status in the cardiac myocyte.  There are multiple reports in the literature, by 
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our group and others, who have clearly demonstrated a direct effect of pyridine 
nucleotides on Kv channel activity in heterologous expression systems (vide 
supra).  To the best of our knowledge, the experiments herein described constitute 
the first demonstration of endogenous Kv channel modulation by pyridine 
nucleotides in a primary cell (cardiac myocyte) and tissue (the perfused heart).      
 In the classical biochemistry perspective, the pyridine nucleotides act as 
electron carriers, supporting oxidation-reduction reactions involved in a variety of 
anabolic and catabolic cellular processes.  In addition to their role in support of 
metabolic oxidoreductase reactions, new roles for these cofactors have emerged 
with recent research.  The pyridine nucleotides are now known to play roles in 
regulation of cell signaling, gene transcriptional regulation, free radical production, 
the thioredoxin and glutathione pathways and as ligands for ion channels.126, 128, 
132, 133 In the case of ion channel modulation, pyridine nucleotide sensitivity, 
particularly differential sensitivity for the oxidized (NAD[P]+) versus reduced 
(NAD[P]H) states, has been proposed as a mechanism to link the metabolic status 
of a cell to its excitability.  When subjected to hypoxic or anoxic conditions, aerobic 
metabolic capacity is diminished, resulting in an accumulation of the reduced 
pyridine nucleotide NADH generated from glycolysis and the tricarboxylic acid 
cycle.  Without available oxygen, this NADH can not be oxidized back to NAD+ 
through the electron transport chain enzymes.  This shift in pyridine nucleotide 
redox putatively may serve as a metabolic queue to alter the conductances of 
various ion channels, integrating metabolic activity with cellular excitability. 
Multiple channels or channel subunits contain nucleotide binding domains which 
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bind pyridine nucleotides with high affinity, including the calcium-activated K+ 
channels Slo1 and Slo2, KATP, the voltage-gated sodium channel Nav1.5, the cystic 
fibrosis transport regulator CFTR, the lysosomal two-pore channel TPC2, the 
transient receptor potential channel TRPM2, the ryanodine receptor RYR, and the 
voltage-gated K+ channel subunit Kvβ proteins.  128  These channels regulate many 
distinct cellular processes involved in cellular metabolism and homeostasis, and 
as such, their regulation by pyridine nucleotides may be a fundamental role of 
these molecules outside of their electron carrying ability.   
Whereas these nucleotides act as ligands to several structurally distinct ion 
channels by poorly understood mechanisms (see APPENDIX), the understanding 
of their molecular interaction with the Kvβ proteins is comparatively well delineated.  
In an elegant set of experiments by Pan et al., 82 serial mutagenesis of residues in 
the core domain and N-terminus of Kvβ1 was employed to determine the molecular 
mechanism by which N-type inactivation is modulated by the redox state of the 
pyridine nucleotide bound to Kvβ1.  Mutants were coexpressed with the delayed 
rectifier Kv1.1 in Xenopus oocytes and giant inside-out patches were pulled; 
patches were depolarized to +60 mV from a -100 mV holding potential and % 
inactivation (i.e. peak current – steady state current at 200 ms).  Patches were 
perfused with 4-cyanobenzaldehyde, previously described to be a reducible 
substrate of the Kvβ proteins.78  Kvβ catalysis of 4-CY into 4-cyanobenzoic acid 
requires the oxidation of the Kvβ-bound cofactor and thus this was utilized as a 
model for assaying the residues involved pyridine nucleotide-dependent 
modulation of N-type inactivation.  These experiments provided the information 
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implicating specific residues in the Kvβ1 core and N-terminal domains responsible 
for restraining the inactivation domain when a reduced nucleotide is present in the 
nucleotide binding domain.  Furthermore, these experiements mechanistically 
linked the enzymatic turnover of substrate with rapid inactivation kinetics, 
elucidating the processes by which both altered availability and redox status of 
cytosolic nucleotides or the presence of an unknown carbonyl substrate may be 
utilized to alter Kv channel conductances and thus cellular excitability.  Thus, this 
raises the interesting question of whether the primary mode of Kvβ-dependent Kv 
channel modulation occurs through shifting cytosolic NAD(P)H/NAD(P)+ ratio or 
through some unknown substrate to which Kvβ has a high turnover rate, or both.  
Further experiments are being performed by our group as well as others to uncover 
the physiological significance of these regulatory axes. 
In this project, cardiac myocyte Kv conductances were altered by 
intracellular dialysis of pipette mixtures containing either high NADH or NAD+ 
concentrations.  Furthermore, modulation of intracellular pyridine nucleotide redox 
status by lactate perfusion altered both cardiac myocyte and whole heart 
repolarization rates.  These are compelling evidences that pyridine nucleotides 
have the ability to modulate cardiac repolarization, but further evidence is required 
to demonstrate that they are endogenous regulators of ion transport or that 
physiological or pathological changes in pyridine nucleotide levels have any effect 
on ion transport.  A more thorough understanding of these relationships may 
require development of new modalities which are capable of simultaneously 
measuring free nucleotide levels and ion channel conductances either in cells or 
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tissue/organ preparations in order to delineate how these processes contribute to 


























Figure 4.1: Cardiac Kv current inactivation..   Whole-cell outward Kv currents were 
elicited in response to a 5s, +50 mV depolarizing pulse from a holding potential of -80 mV 
and fit triexponentially.  Current inactivation was accelerated under hypoxic pipette 
conditions.  Representative amplitude-normalized Kv currents (A).  Inactivation time 
constants for tau 2 (corresponding to Ik,slow1) and tau 3 (corresponding to Ik,slow2) were shorter 
under hypoxic pipette mix conditions. .  Pipette internal solutions contained either normoxic 
(high NAD+) or hypoxic mixes (high NADH) of pyridine nucleotides. n= 19 cells (normoxic), 



























Figure 4.2:  Perfusion of hearts in Langendorff mode with lactate.  
Hearts were perfused ex vivo with lactate 20 mM (Lactate +) for 20 
minutes and flash frozen for later measurement of pyridine nucleotides.  
Cellular NADH concentration increased significantly in both WT (top) 
and Kvβ2-/-  compared to controls perfused with standard Tyrode’s 
buffer (Lactate -).  n= 3 hearts WT and 3 hearts Kvβ2-/- for each 
treatment.  *: p<0.05. These experiments were performed in 
collaboration with Dr. Srinivas Tipparaju and Dr. Kalyan 
Chapalamadugu at the University of South Florida Department of 










Figure 4.3:  Lactate perfusion causes action potential prolongation in WT but not Kvβ2-/- 
hearts.  Monophasic action potentials were recorded from Langendorff perfused hearts during 
control (Lactate -) and following lactate 20 mM perfusion for 15 minutes (Lactate +).  A. WT hearts 
displayed prolonged action potential durations (APD).  B. Action potential duration at 20, 50, and 90 
% repolarization was increased.  C. Kvβ2-/- repolarization was not sensitive to lactate.  D. Action 
potential durations in Kvβ2-/- were not changed from control. n=5 hearts WT and 5 hearts Kvβ2-/-  
*:p<0.05.  These experiments were performed in collaboration with Dr. Srinivas Tipparaju and Dr. 








Figure 4.4: Action potential prolongation caused by lactate is rescued by 
perfusion with pyruvate.  Monophasic action potentials were recorded on hearts as 
they were perfused with control Tyrode’s (Lactate -) for 15 min, followed by 20 mM 
lactate (Lactate +) for 20 minutes followed by 20 mM pyruvate (Pyruvate +) for 20 
minutes. Pyruvate perfusion shortened APD90 back to control values. n=5 hearts.  *: 
p<0.05.  These experiments were performed in collaboration with Dr. Srinivas Tipparaju 
and Dr. Kalyan Chapalamadugu at the University of South Florida Department of 










Figure 4.5: Cardiac myocyte action potentials are prolonged by lactate 
superfusion.  Single cell action potentials were recorded in WT cardiac 
myocytes (n=6) in the perforated patch configuration to allow intracellular 
NADH accumulation during lactate perfusion.  A.  Representative traces 
recorded during control (black) and following 8 min 10 mM lactate superfusion.  
B.  Action potential duration at 50% repolarization was significantly prolonged.  
C.  Action potential amplitude, resting membrane potential and upstroke 
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Figure 4.6: Single channel Kv activity in cardiac myocyte inside-out patches is 
increased by NADH.  A.  Single channel activity was recorded from excised patches 
pulled from cardiac myocytes perfused with control buffer. B. When 1 mM NADH was 
added to the perfusate, single channel event activity increased approximately 10-fold 
(percentage of time the channel spend in the closed state.) C.  P(closed) was calculated 
for each 5 second sweep during 4 minutes of control and 6 minutes of 1 mM NADH 
























Scheme 4.1:  Lactate dehydrogenase reaction.  Langendorff-perfused hearts and 
cardiomyocytes in perforated patch configuration were perfused with 10 mM or 20 
mM sodium lactate in order to drive the LDH reaction to produce elevated cytoplasmic 
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Bacterial Potassium Transporters 
It is currently believed that life originated in an aqueous environment in 
which negatively charged biomolecules, such as proteins and nucleic acids, were 
trapped in a semipermeable membrane. The high osmotic pressure exerted by 
charged biomolecules was counterbalanced by a high concentration of positively 
charged K+ ions within the membrane-delimited cell. This intracellular 
accumulation of K+ and exclusion of the more abundant seawater cation, Na+ was 
probably used to energize the cell membrane. As a result, all living cells tightly 
regulate K+ transport and use K+ as the major solute to control osmolarity. The 
regulation of K+ transport is critically important not only for survival and growth but 
also for maintaining cytosolic pH and for transmitting information from the 
extracellular to the intracellular environment. Although it is unknown how archaic 
cells regulated K+ transport, modern bacteria, such as Escherichia coli, maintain 
separate systems for K+ uptake and efflux. Transport systems, such as Trk, Ktr, 
and T2M channels, mediate active uptake of K+ ions, whereas K+ efflux is effected 
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by the Kef system. Remarkably, all 4 of these transport systems possess a 
nucleotide-binding potassium transport nucleotide–binding domain (KTNBD).134, 
135  In uptake systems, this domain is in the cytosolic subunits (TrKA or KtrA) that 
assemble with the membrane-spanning subunits (TrkG/H or KtrB/D), whereas in 
systems mediating K+ efflux (KefC/B), the KTNBD is covalently linked to the 
cytosolic C-terminus of the ion transporter. In both instances, the cytosolic location 
of the NBD suggests a sensing mechanism in which ligand binding to the 
intracellular domains of the transporter could alter K+ flux through the ion-
conducting pore. This possibility is reinforced by the invariant proximity of the 
KTNBDs to the base of the innermost pore-forming helices134, suggesting that 
conformational changes in the KTNBD could readily alter the ion transport 
properties of the pore. The KTNBDs of bacteria form a well-conserved Rossmann 
fold, which is a stable NAD+-binding motif composed of 6 parallel β strands linked 
to 2 pairs of α-helices. This fold is commonly found in several bacterial and 
eukaryotic dehydrogenases. The Rossmann fold of KtrA binds to both NAD+ and 
NADH. Binding of these ligands is essential for the maintenance of the tetrameric 
state of KTNBD and ligand-mediated changes. This could impart conformational 
changes in the ion-transporting subunit to alter its conducting properties,134 
although this has not been directly demonstrated. 
Like KtrA, the K+ uptake proteins TrkG/H also interact with subunits (TrkA) 
containing the KTNBD. The TrkA subunit of TrkG/H has 2 distinct dinucleotide-
binding sites in each of 2 similar subdomains and, in addition to TrkG/H, TrkA also 
interacts with several other proteins, such as TrkE, to form functional channels. 
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Each half of the protein sequence of TrkA aligns with NAD+-dependent 
dehydrogenases, such as lactate, malate, and alanine dehydrogenase, and 
purified TrkA binds NAD+ and NADH with much higher affinity than ATP.136  
Because TrkA lacks the C-terminal catalytic domain of dehydrogenases, it is 
considered unlikely that the protein has enzyme activity. Nevertheless, it has been 
proposed that binding of NAD(H) to TrkA regulates the transport activity of the 
TrkG and the TrkH systems,134 but the functional regulation of Trk transporters by 
NAD(H) has not been directly demonstrated to date. However, the presence of a 
pyridine NBD in TrkA suggests potential coupling between energy expensive 
import of K+ ions and active metabolism. This coupling might be particularly 
important during cell growth. A high NADH:NAD+ ratio is a prerequisite for cell 
growth, and activation of K+ import by pyridine nucleotides may be required to 
maintain cytoplasmic K+ levels and turgor pressure during cell expansion.134  
In contrast to the K+ uptake systems, which associate with nucleotide-
binding proteins, the K+-efflux system, KefC, has a KTNBD that is covalently linked 
to its ion-transporting subunits. The KefC transport system is inactivated by 
reduced glutathione, and it is activated by glutathione-S-conjugates.137  Activation 
of this transport by glutathione conjugates leads to acidification of the cytosol. 
Because thiol reactivity is decreased at low pH, this might be a strategy for 
preventing the modification of cytosolic protein thiols, and thereby for protecting 
the bacteria from electrophilic stress. The C-terminal KTNBD of KefC is similar in 
structure to the Rossmann fold of dihydrofolate reductase and it binds glutathione. 
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Inhibition of KefC by glutathione is enhanced by NADH, but not NAD+, indicating 
that NADH:NAD+ ratio could regulate the antiporter activity of KefC.138 
In addition to glutathione and NADH, the KTNBD of KefC also binds to the 
auxiliary subunits, KefF and KefG, which are required for the full activation of 
KefB/C.139 The primary sequences of KefC and KefG show striking resemblance 
to human quinone reductases and in the crystal structure of KefF, FMN is bound 
to the KTNBD of the protein.140  Recently, it has been shown that the KefF is a 
bonafide oxidoreductase in which NADH and NADPH act as electron donors and 
quinones and ferricyanide act as acceptors.141  Although enzyme activity was not 
found to be required for KefC activation, it was suggested that by catalyzing the 
reduction of quinones, KefF protects KefC from the toxicity of electrophilic 
quinones.141  
As discussed, the link between K+ channels and nucleotide-binding proteins 
in bacteria is conserved in eukaryotic K+ channels. Like the bacteria efflux systems 
(Kef), some of the eukaryotic channels, such as the Slo channels, possess a 
nucleotide-binding site in their cytosolic domain, whereas others, such as Kv 
channels, associate with auxiliary subunits that bind pyridine nucleotides in a 
manner reminiscent of the bacterial K+ uptake systems (Trk/Ktr). Moreover, like 
bacterial channels, the mammalian K+ channels also are regulated by pyridine 
nucleotides. It is likely that this mode of regulation is conserved during evolution 
because it plays a critical, nonredundant role in linking K+ transport to the 
metabolic state of the cell, thereby enabling the cell to sense and respond to 
changes in the external environment. 
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Slo K+ Channels 
The Slo family comprises high-to-intermediate conductance channels with 
a C-terminal domain that bears close resemblance to TrkA and other NAD+-binding 
prokaryotic K+ transporters.142 These channels are widely distributed across 
Linnaean borders and are expressed in many types of cells, including cardiac 
myocytes and smooth muscle cells. The 4 mammalian Slo genes, Slo1 (BKCa), 
Slo2.1 (Slick), Slo2.2 (Slack), and Slo3, encode proteins that form K+-selective 
homotetrameric channels.143  The core region of these channels resembles the 
canonical Kv channels, but their cytoplasmic domain shows unusually high 
structural diversity. Variations in the cytosolic domain enable these channels to 
respond to a wide range of intracellular ions and metabolites. The cytosolic region 
of Slo1 binds to calcium via the calcium bowl located at the distal end of its 
hydrophilic tail; therefore, these channels are sensitive to changes in both 
membrane potential and [Ca2+]i. The Slo2.1 channel is regulated by Cl−, but it 
contains an ATP-binding domain as well. The Slo2.2 channel is insensitive to Cl− 
and it does not bind ATP. Nevertheless, both Slo2 channels respond to elevated 
[Na+]i levels, giving rise to the KNa current.144 
Initial work showed that the KNa channels are sensitive to sodium only at 
supraphysiological levels (50–80 mmol/L), making it doubtful whether they could 
be regulated by physiological changes in [Na+]i that usually vary between 5 and 15 
mmol/L.145 Channel run-down after initial excision also was frequently observed. 
These discrepancies remained unresolved until Tamsett et al142 found that the 
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cytoplasmic domain of both Slo2.1 and Slo2.2 contains NBDs similar to TrkA. This 
site includes a canonical NAD+-binding βαβαβ motif that was required for 
nucleotide binding. They also found that application of physiological levels of NAD+ 
to inside-out patches of rat dorsal root ganglion neurons led to a 2- to 2.5-fold 
increase in the open probability of KNa channels and a decrease in EC50 of Na+ 
from 50 to 20 mmol/L. The specificity of this interaction was reinforced by the 
finding that other cytosolic factors (cAMP, cGMP, and ATP) were without effect.146  
NAD+, but not NADH, was effective in altering the gating properties of the channel, 
but only in the presence of Na+. Moreover, like native KNa channels, the current 
generated by Slack channels also was increased by NAD+ or NADP+. Site-directed 
mutations at the NAD+-binding site of the Slo2 channel abolished this response, 
suggesting that direct nucleotide binding to the cytosolic region of the channel is 
required for these channels to respond to changes in pyridine nucleotide levels. 
The regulation of KNa/Slo2 channels by NAD(P)+ suggests that the activity 
of these channels may be coupled to the metabolic state of the cell. This mode of 
regulation may be particularly important during ischemia–reperfusion and other 
conditions in which accumulation of NAD(P)+ could increase K+ efflux via these 
channels. High levels of intracellular NAD(P)+ also would increase the sensitivity 
of these channels to intracellular sodium. Indeed, it has been suggested that in 
ischemic cardiac myocytes, elevated [Na+]i levels activate KNa, and an increase in 
this current shortens the action potential duration and induces calcium overload.147, 
148 Therefore, regulation by pyridine nucleotides would allow these channels to 
adapt simultaneously to both the metabolic and the ionic conditions prevalent in 
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the ischemic heart. Interestingly, even though the evidence is indirect, it has been 
proposed that the Slo2 channels are present in cardiac mitochondria.149  If present, 
the regulation of these channels by pyridine nucleotides might represent 
conservation of the link between metabolism and ion transport in modern 
mitochondria and their prokaryotic ancestors. 
The NAD+-binding site of Slo2 resembles the calcium binding site of the 
cytoplasmic domain of Slo1 channels, which contain 2 regulators of potassium 
conductance domains.143 The regulator of potassium conductance domain is 
similar to the KTNBD of bacterial channels134  found in 6-transmembrane K+ 
channels, except that in the KTNBD the nucleotide binding Rossmann fold is not 
conserved. The N-terminus of the regulator of potassium conductance domain of 
Slo1 forms a Rossmann fold, which is similar to that seen in the structure of the 
cytoplasmic region of Slo2.2150; however, amino acid replacements in this domain 
during evolution have recruited the structure to bind calcium ions in case of Slo1 
and sodium in case of Slo2.2. Although no direct pyridine nucleotide binding to the 
regulator of potassium conductance domain of Slo1 channels has been 
demonstrated, Lee et al151 have reported that application of 2 mmol/L NAD+ to the 
internal face of excised patches from small (<300 μm) pulmonary arteries reduces 
the open probability of BKCa channels, whereas NADH has the opposite effect. 
However, pyridine nucleotides had no effect on steady-state BKCa conductance 
in ear arterial smooth muscle cells151 or in large (>300 µm) intralobar pulmonary 
arteries,152 although in large arteries, application of NADH did lead to a voltage-
dependent block of the channel.  Although these observations are intriguing, 
 122 
further studies are required to understand how intracellular changes in pyridine 
nucleotides regulate the activity and the physiological role of Slo channels. 
 
Kv2.1 Channels 
Like members of the Kv1 and Kv4 family, the Kv2.1 channels also have 
been shown to be sensitive to the redox ratio of pyridine nucleotides. MacDonald 
et al153 have reported that in whole-cell recordings of Kv2.1 from pancreatic β-cells, 
increasing the NADPH:NADP+ ratio in the patch pipette from 1:10 to 10:1 
increased the contribution of fast inactivation to total inactivation from 40% to 60%. 
The effects, however, were modest and could not be duplicated by Yoshida et al.154  
Moreover, it is unclear how Kv2.1 is regulated by NADP(H). The Kv2.1 protein 
does not associate with pyridine-binding subunit, such as Kvβ, and direct binding 
of pyridine nucleotide to Kv2.1 has not been demonstrated. Although it is possible 
that changes in NADPH/NADP+ levels could also affect Kv2.1 currents indirectly 
by changing cell metabolism or kinase activation, there is no evidence to support 
this possibility. Moreover, the physiological significance of the redox sensitivity of 
Kv2.1 in insulin secretion is unclear, because it has been reported that changes in 
Kv2.1 channels do not affect the levels of the critical pool of subplasma membrane 
calcium that regulates exocytosis.155 Because NADPH facilitates insulin 
exocytosis,156 it has been speculated that the binding of NADPH increases the 
association of Kv2.1 with SNARE proteins, which facilitates granule docking or 
priming.157  Although this is an interesting possibility, additional investigations are 
required to fully elucidate the relationship between NADP(H) and Kv2.1 and to 
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assess its importance in regulating insulin secretion or other physiological 
phenomena. 
 
Voltage-gated Sodium Channel 
The voltage-gated sodium channel (Nav) conducts the fast inward sodium 
current that gives rise to the upstroke of the action potential and regulates the 
action potential duration. Therefore, small changes in sodium current profoundly 
impact myocardial excitability and conductance and such changes attributable to 
genetic mutations increase myocardial susceptibility to arrhythmias. Several gain-
of-function and loss-of-function mutations in the cardiac channel (SCN5A) and its 
auxiliary subunits (Nav β1–β4 subunits) have been linked to arrhythmic 
syndromes, such as the long Q-T (LQTS type 3), the Brugada, the sick sinus, and 
the sudden infant death syndromes.158  In a large multigenerational family of Italian 
descent with Brugada syndrome159 and in several cases of sudden infant death 
syndrome,160 the pathogenic cause has been identified to mutations in the glycerol-
3-phosphate dehydrogenase-1-like protein (GPD1-L), which decrease surface 
trafficking of SCN5A and the peak sodium current. The importance of GPD1-L is 
further underscored by recent evidence showing that common variations in or near 
GPD1-L are associated with increased risk of sudden cardiac death in patients 
with coronary artery disease.161  
GPD1-L is a 40-kDa protein that shares 84% sequence homology with 
GPD, an oxidoreductase that converts dihydroxyacetone phosphate to glycerol-3-
phosphate. Because glycerol-3-phosphate is required for lipid synthesis, the 
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activity of GPD connects carbohydrate metabolism to lipid synthesis. GPD also 
contributes electrons to the mitochondrial electron transport system and maintains 
the redox status of the pyridine nucleotide levels in the mitochondria by 
participating in glycerol phosphate shuttle. GPD1-L displays glycerol phosphate 
dehydrogenase activity, although its catalytic activity is slower than that of GPD.162, 
163 Results of GST pull-down assays in a heterologous expression system suggest 
that GPD1-L is directly or closely associated with the pore-forming α-subunit of 
SCN5A.162 GPDL-1 mutations that have been linked to Brugada syndrome 
(A280V) and sudden infant death syndrome (E83K) decrease GPDL-1 activity, but 
do not alter its association with SCN5A.162  However, these mutations decrease 
the surface expression of SCN5A, thereby reducing total INa.159, 162   This 
phenomenon is reminiscent of the behavior of Kvβ, which is also an 
oxidoreductase that regulates the surface expression of its pore-forming partner 
(Kv1). As seen with GPDL-1, loss-of-function mutations also decrease the effects 
of Kvβ on Kv1 trafficking.164  
The close association between Nav and GPD1-L suggests that the sodium 
current may be sensitive to redox chemistry. Patch-clamp experiments of Dudley 
et al165  show that in rat neonatal cardiac myocytes and in HEK cells expressing 
SCN5A, intracellular dialysis with 20 to 100 μmol/L NADH directly inhibits and that 
this is antagonized by incubating the cells with NAD+. This inhibition of INa was 
linked to NADH-dependent protein kinase C (PKC) activation or mitochondrial 
superoxide generation.165 However, the processes by which NADH could stimulate 
PKC have not been identified and it was unclear how activated PKC could increase 
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mitochondrial reactive oxygen species production. Moreover, NADH-mediated INa 
suppression was not accompanied by changes in the inactivation of the channel 
or the induction of window current or a late sodium current, usually seen in cardiac 
myocytes exposed to oxidants.166-168  Valdivia et al 162 suggest that at least some 
of the effects of NADH on sodium current may be attributable to changes in GPD1-
L activity, because they were completely abolished by inhibiting PKC, indicating 
that NADH has no direct effects on Nav. They link PKC activation to GPD1-L 
activity, suggesting that NADH increased the production of glycerol-3-phosphate 
by GPD1-L, which increases diacylglycerol formation. This increase in 
diacylglycerol stimulates PKC activity and results in greater SCN5A 
phosphorylation. Moreover, they found that PKC activation acutely decreases the 
surface expression of SCN5A and this effect is prevented by the NADPH oxidase 
inhibitor apocynin, suggesting that both channel phosphorylation and reactive 
oxygen species production are required for PKC-mediated regulation of SCN5A 
trafficking.162, 169_ENREF_153 However, these signaling pathways have been 
delineated mostly in heterologous systems and, therefore, additional experiments 
are required to determine endogenous regulation of INa by pyridine nucleotide in 
cardiac myocytes (or neurons) and to determine whether GPD1-L and pyridine 
nucleotide–dependent changes in PKC activation and reactive oxygen species 
generation affect only sodium channels or other ion transport mechanisms as well. 
 
ATP-regulated K+ Channels 
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The ATP-regulated K+ channels represent another class of K+ channels that 
are regulated by nucleotides. Although these channels are primary regulated by 
ATP, they also have been found to be sensitive to pyridine nucleotides as well. 
The effects of pyridine nucleotides on the KATP channels were first described by 
Dunne et al,170 who reported that in excised patches of insulin-secreting cells low 
(100 μmol/L) concentrations of NAD(P)+ and NAD(P)H promoted channel opening, 
whereas high concentrations (500 μmol/L) led to channel closure. These effects 
were modified by ATP and ADP, indicating that pyridine coenzymes compete with 
adenine nucleotides for the NBD of the channel. 
The KATP currents are generated by a large conductance channel present 
in the plasma membrane of several tissues, including the heart, smooth muscle, 
and pancreatic β-cells.171, 172 An ATP-dependent potassium conductance has also 
been identified in the mitochondria,173, 174  which has recently been found to be 
attributable to a channel related to the ROMK (Kir1.1) channel of the renal outer 
medulla.175  The sarcolemmal KATP channels open when the cellular 
concentrations of ATP are low and are blocked at high ATP levels. These channels 
are formed by the 4 pore-forming Kir6.2 subunits and 4 regulatory sulfonylurea 
receptor (SUR2A) subunits. The current is inhibited by the binding of adenine 
nucleotides to Kir6.2. Moreover, the NBD of SUR interacts specifically with Mg–
nucleotide complexes, resulting in channel opening.171  Therefore, in any given 
metabolic state, the activity of the channel is a balance between the stimulatory 
and inhibitory effects of adenine nucleotide binding. Experiments with Kir6.2/SUR1 
expressed in Xenopus oocytes have shown that inhibition of these currents by 
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NAD+ and NADP+ is mediated via binding to the Kir6.2 NBD, but not to the SUR1 
NBD. The affinity of Kir6.2 for NADP(H) is markedly enhanced on interaction with 
SUR1, perhaps because modification of the nucleotide-binding pocket of Kir6.2 by 
SUR1 facilitates the attachment of molecules bulkier than adenine 
mononucleotides, such as NADP(H).176  Nevertheless, the physiological 
significance of this interaction has not been assessed, and it is not clear whether 
the cardiac SUR2A isoform responds similarly. Because pyridine nucleotides are 
much less potent in inhibiting IKATP, it is likely that these nucleotides make only a 
small contribution to inhibition of the channel. Moreover, because the Kir6.2 
displays no specificity for oxidized or reduced species but responds only to bulk 
nucleotide concentrations, it cannot participate in modulation of membrane 
potential by the redox state of pyridine nucleotides. Additionally, the ability of low 
concentrations of pyridine nucleotides to increase the activity of native KATP 
channels in pancreatic cells170 was not observed in oocytes expressing 
Kir6.2/SUR1.176  Clearly, additional work is required to elucidate the mechanism of 
binding of low levels of pyridine nucleotides and to assess the significance of 
binding to physiological levels of NADP(H). Nevertheless, because pyridine 
nucleotides levels change under conditions that affect ATP levels, it is likely that 
native KATP channels are sensitive to both adenine and pyridine nucleotides. 
Like the sarcolemmal KATP channel, the mitochondrial KATP currents also 
respond to pyridine nucleotides. Measurements of mitochondrial KATP activation by 
osmotic swelling indicate that the channel activity could be inhibited by NADPH.177  
The inhibition of the channel could not be related to reduction of mitochondrial 
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thiols and, therefore, was ascribed to direct regulation of the channel activity by 
NADPH. These observations suggest that the regulation of mitoKATP channels by 
NADPH may be a physiological mechanism for sensing changes in energy 
metabolism and the redox status of mitochondria, but extensive work will be 
required to determine whether pyridine nucleotides are endogenous regulators of 
mitochondrial K+ transport. 
 
Cystic Fibrosis Transmembrane Conductance Regulator 
The cystic fibrosis transmembrane conductance regulator is an ATP-
binding cassette ion exchanger responsible for moving chloride and thiocyanate 
ions across epithelial cell membranes. Mutations in this gene create a 
nonfunctional protein that does not transport chloride and water in and out of cells 
that line the lungs, the pancreas, the liver, and the reproductive and digestive 
tracts. This disruption of osmotic gradients results in the production of abnormally 
viscous mucous, causing the obstruction of the respiratory tract characteristic of 
cystic fibrosis, as well as chronic dysfunction of other affected organs. The cystic 
fibrosis transmembrane conductance regulator acts as a cAMP-activated ATP-
gated ion channel that allows Cl− ions to flow down their electrochemical gradient 
and exit the cell. It has been reported that pyridine nucleotides can interact with 
the NBD of cystic fibrosis transmembrane conductance regulator and that the 
redox potential of pyridine nucleotides regulates the Cl− conductance of the 
channel.178  It was found that when ATP levels were clamped, there was a marked 
increase in Cl− conductance on dialysis of the cell with NADP+. In contrast, dialysis 
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with NADPH inhibited Cl− conductance. Although these studies point to an 
intriguing link between the redox state of pyridine nucleotides and Cl− 
conductance, no studies seem to have followed-up on these initial findings. 
 
Transient Receptor Potential (TRP) M2 Channel 
Pyridine nucleotides and their metabolites also regulate calcium transport 
and homeostasis. Although the effects of pyridine nucleotides on the voltage-
dependent calcium channels have not been reported, recent work has shown that 
NAD+ regulates calcium homeostasis by modifying the activity of TRPM2 channel 
(TRPM2). The transient receptor potential (TRP) M2 channel belongs to a large 
TRP superfamily which comprises several 6 transmembrane cation channels 
involved in a variety of processes ranging from sensation of touch, smell, taste, 
pain, temperature, osmotic pressure, and apoptosis.179  A distinguishing feature of 
the TRPM2 channel is the presence of a cytosolic nudix hydrolase domain in the 
C-terminus of the channel that is highly homologous to the ADP pyrophosphatase 
NUDT9 and is therefore named the NUDT9-homologous domain (NUDT9-H). The 
NUDT9 domain of ADP pyrophosphatase displays 39% sequence identity with 
TRPM2 and is a member of the Nudix family of proteins, such as 8-oxo-dGTP 
hydrolase (MutT) and diadenosine tetraphosphate pyrophosphatase (AP4A 
hydrolase).180  TRPM2 is highly abundant in the brain, but it is also expressed in 
other tissues, including, spleen, liver, lung, heart, and myeloid cells.181  The 
channel is nonselective for cations and displays a nearly linear current–voltage 
relationship with a reversal potential near 0 mV.182  The physiological functions of 
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TRPM2 have not been completely elucidated, but there is evidence showing that 
the channel is involved in monocyte chemotaxis183, insulin secretion by pancreatic 
β-cells184, and lysosomal calcium release.185  Studies with TRPM2-null mice 
suggest that the channel controls the production of chemokines in monocytes and 
the infiltration of neutrophils during inflammation.186  Because TRPM2 is highly 
responsive to oxidative stress, it is likely that this channel could function as a redox 
sensor187  by directly binding to NAD+ or its metabolite, ADPR. 
Data from whole-cell patch-clamp experiments show that intracellular 
dialysis with NAD+ 188 evokes a large inward current in cells expressing TRPM2 
channels. In excised patches, application of NAD+ lead to instantaneous activation 
of the channel, suggesting that NAD+ directly activates the channel without the 
involvement of cytoplasmic or membrane components. However, regulation of the 
channel by NAD+ remains controversial. Some investigators suggest that 
stimulation of the channel by NAD+ may be attributable to contamination of the 
commercially available NAD+ preparations that contain trace levels of ADPR, 
which is the natural ligand of the channel.189  Nevertheless, direct binding of 32P-
NAD+ to a GST fusion protein of the C-terminal domain of TRPM2184, 187 suggests 
that the channel protein interacts with NAD+, presumably as it does with ADPR. 
Moreover, even though trace contamination by ADPR could account for the effects 
of 1 mmol/L NAD+, channel activation at higher temperature also has been 
observed at 300 μmol/L NAD+ 184 and only minimal channel activation was 
observed with 10 μmol/L ADPR188 (EC50 ≈100 μmol/L),182 suggesting that 
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contamination with >10% ADPR would be required to fully account for pronounced 
channel activation by commercial NAD+ preparations. 
The binding of 32P-NAD+ to the C-terminus of TRPM2 channels indicates 
that NAD+ interacts with ADPR binding site of the Nudix domain. The importance 
of this domain has been confirmed by experiments showing that deletion of the C-
terminus abolishes the activation of the channel by both ADPR and NAD+.187, 190  
Hara et al187 have suggested that H2O2 activates TRPM2 by increasing the 
intracellular NAD+, which precipitates cell death by inducing calcium and sodium 
overload. A similar NAD+-activated conductance, reminiscent of the TRPM2 
activity, also has been implicated in rat striatal neuron cell death induced by cell 
depolarization and calcium influx.191  Additionally, it has been reported that a 
similar NAD+-gated nonselective cation channel is activated in CRI-G1 rat 
insulinoma cells treated with H2O2.192 The findings of these studies suggest that 
stimulation of TRPM2 by NAD+ could activate cation influx and trigger cell death. 
Similarly, in cardiac myocytes, activation of TRPM2 and the resultant sodium and 
calcium overload have been proposed to be obligatory steps in H2O2-mediated 
apoptosis.124  Nonetheless, it remains unclear whether myocardial oxidative injury 
in vivo during ischemia–reperfusion could be attributed to TRPM2 activation and 
whether this is mediated by NAD+ binding to the channel. Further experiments with 
TRPM2-null mice are warranted to rigorously delineate the role of TRPM2 in 
myocardial ischemic injury and heart failure and to determine whether the activity 
of the myocardial channel is regulated by NAD+. 
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In addition to its direct effects on the channel, NAD+ could affect the 
regulation of TRPM2 by its endogenous ligand, ADPR, or inhibit the catalytic 
activity of the C-terminal domain of the channel. It is currently believed that TRPM2 
is activated by ADPR generated from the cleavage of NAD+ by CD38.193 Thus, 
NAD+ levels could indirectly affect TRPM2 activity by regulating the supply of 
ADPR. NAD+ also could compete with ADPR binding and catalysis. The NUDT9 
domain of the channel has low levels of ADPR pyrophosphatase activity182 which 
could be inhibited by NAD+ and other pyridine nucleotides and their metabolites, 
although this possibility has not been directly tested. Regardless, the presence of 
a catalytic domain within the channel is fascinating because it indicates that as 
seen with the bacterial Kef system, the TRPM2 channels belong to a distinct class 
of channel proteins that possess catalytic activity. Even though the enzymatic 
activity of NUDT9 is considerably lower than in the ADPR pyrophosphatases, this 
may be an evolutionary adaptation to increase the dwell time of ADPR at the 
channel.190 Moreover, mutations of the catalytic domain that increase enzymatic 
activity of NUDT9-H decreased channel activity, suggesting that nucleotide 
binding, not catalysis, activates the channel. Notably, the interesting possibility that 
channel gating or ion flow modulates the catalytic activity of NUDT9-H has not 
been tested. 
 
Ryanodine Receptor (RyR) Calcium Release Channel 
The RyRs represent another class of ion channels that may be regulated by 
pyridine nucleotides. Sequence analysis and homology modeling studies show 
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that the RyR of the skeletal muscle (RyR1) contains several dehydrogenase and 
NAD+/NADH oxidoreductase domains.194 This region is located near the N-
terminus of the RyR1 and it shows significant structural homology to isocitrate 
dehydrogenase and isopropylmalate dehydrogenase. It also contains additional 
motifs related to the alcohol dehydrogenase. Notably, several of the residues that 
participate in NADP+ binding in isocitrate dehydrogenase are conserved in RyR1, 
suggesting that the channel may be capable of binding to pyridine nucleotides. 
Indeed, equilibrium-binding studies indicate low-affinity binding of [3H] NAD+ to the 
sarcoplasmic reticulum membrane (Kd=10 μmol/L), although kinetic studies 
indicate a much higher affinity (Kd=50 nmol/L). On the basis of these studies, it 
has been estimated that nearly 10 molecules of NAD+ bind to each subunit of 
RyR1.194  Sequence alignment demonstrates that the the cardiac RyR2 protein 
shares ≈82% homology with RyR1 between amino acids 41 and 1200, and that 
this region of the protein contains multiple nucleotide-binding sites with significant 
structural and sequence homology to phosphorylated isocitrate dehydrogenase. 
The same region also encompasses both catalytic and binding sequences 
common to dehydrogenases and oxidoreductases. 
The results of structural and biochemical studies are consistent with 
functional measurements. In permeabilized ventricular myocytes, addition of 
NADH decreases the frequency of calcium sparks,195 and this inhibitory effect of 
NADH is partially reversed by NAD+, although NAD+ by itself has no effect on 
calcium spark frequency. These findings suggest that an increase in NADH/NAD+ 
(eg, during ischemia) could inhibit spontaneous sarcoplasmic reticulum calcium 
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release. Nevertheless, the biochemical basis and the physiological significance of 
these findings are yet to be established. Particularly, it is unclear whether these 
effects are because of direct binding of NAD+ to RyR or because of some other 
indirect NAD+-dependent changes, such as increased superoxide generation by 
NADH oxidase.196 
Although NAD+ does not activate calcium sparks in permeabilized 
myocytes, addition of 1 µmol/L NAD+ increases the open probability of single RyR2 
cardiac calcium release channels incorporated into planar phospholipid bilayers.197  
A similar increase has been reported for skeletal muscle RyR1 channels; in which 
case, addition of 1 to 10 μmol/L NAD+ led to a 7- to 80-fold increase in open 
probability.198 These observations suggest that NAD+ can directly activate calcium 
release channels; however, additional investigations are required to fully assess 
the role of pyridine nucleotides in regulating the calcium release channels, to 
determine whether the oxidoreductase domains of the RyR are catalytically active, 
and whether this catalysis regulates calcium release by the channel. 
 
Regulation of Calcium Signaling by NAADP+ 
In addition to directly regulating ion transport, pyridine nucleotides also generate 
specialized metabolites that regulate cell signaling, particularly calcium fluxes. The 
most potent of these metabolites is nicotinic acid adenine dinucleotide phosphate 
(NAADP+), which stimulates calcium release in different cell types at 
concentrations as low as 5 to 10 nmol/L. Activation of calcium release by NAADP+ 
has been found to regulate several physiological processes, including fertilization, 
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neurite outgrowth, synaptic function,199 and insulin secretion.200 NAADP+ also 
mobilizes calcium stores in smooth muscle cells201  and cardiac myocytes.202  In 
endothelial cells, NAADP+ has been recognized as an essential mediator of 
histamine-induced secretion of von Willebrand factor203  and a regulator of nitric 
oxide production.204  On the basis of the observation that intravenous 
administration of a cell permanent NAADP-ester lowers blood pressure in rats, it 
has been suggested that NAADP+ regulates systemic blood pressure.204  
NAADP+ is an NADP+ derivative in which the nicotinamide ring is replaced 
by nictonic acid. This structural difference may be sufficient in preventing NAADP+ 
binding to most NADP+-binding proteins, and in promoting specific recognition of 
NAADP+ by its cognate receptors. The biochemical processes involved in NAADP+ 
synthesis have not been completely identified. In vitro NAADP+ is synthesized from 
NADP+ by both ADP-ribosyl cyclases and CD38,205 but it is not clear whether these 
enzymes synthesize NAADP+ in vivo. Measurements of basal NAADP+ levels in 
several tissues show that CD38-null mice maintain normal NAADP+ levels.206 
Moreover, increases in NAADP+ levels in histamine-stimulated myometrial cells206 
and in glucose-stimulated islet cells200 are preserved in the absence of CD38, 
although NAADP+ generation in response to CCK stimulation in pancreatic acinar 
cells207 is attenuated. Thus, at least in some cells, NAADP+ synthesis seems to be 
CD38-independent and it is likely that there are additional enzyme(s) involved in 
generating basal and agonist-evoked NAADP+. 
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Agonist-stimulated increase in NAADP+ levels is associated with release of 
calcium from intracellular stores that are different from those mobilized by IP3 or 
cyclic ADPR.208 It is currently believed that NAADP+ targets lysosome-related 
stores as some of its effects are inhibited by depletion of acidic calcium stores, but 
not by inhibitors of sarco/plasmic or endoplasmic reticulum Ca2+-ATPase. The 
ability of NAADP+ to release calcium from lysosomes has been related to the 
activation of 2-pore channels (TPCs).209, 210 These channels contain 2 putative 
pore-forming repeats and their transmembrane regions are similar to that of other 
channels, such as the Nav or TRP channels however, instead of the plasma 
membrane, these channels are located in the endolysosomes and lysosomes or 
the ER. To date, 3 genes encoding TPCs (TPCN1-3) have been identified, of which 
TPCN2 is the predominant form expressed in primates and humans. Cells 
expressing TPC2 show a marked increase in calcium release on intracellular 
dialysis with 10 nmol/L NAADP+. Conversely, genetic knockdown of these 
channels abolishes NAADP+-induced calcium release, indicating that TPCs are 
endogenous targets of NAADP+.208 However, in addition to TPCs, NAADP+ also 
activates RyR211 and TRP subtype mucolipin 1 (TRP-ML1)212 and, at high 
concentrations, the TRPM2213 channels. The role of each of these channels in 
shaping the overall calcium response to NAADP+ is not clear, but it has been 
suggested that responses of multiple NAADP+ targets are integrated such that the 
small localized release of calcium by NAADP+ via TPCs is amplified by neighboring 
receptors to generate well-orchestrated calcium oscillations. 
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The molecular mechanisms by which NAADP+ regulates TPCs remain to be fully 
elucidated. Data from HEK-293 cells show that relative to wild-type cells, cells 
stably overexpressing TPC2 display increased [32P] NAADP+ binding at high-
affinity (Kd=5 nmol/L) and low-affinity (Kd=10 μmol/L) sites.210 However, the results 
of photoaffinity studies using radioactive 5-azido NAADP+ show no direct binding 
to the TPC protein. These studies, however, did show that some unknown low-
molecular-weight proteins were labeled by [32P] NAADP+ and that the labeling of 
these proteins was preserved in TPC-null cells.214 These observations suggest that 
similar to what has been observed with other pyridine coenzyme–regulated 
channels (eg, Kv channels), there might be ancillary proteins within the larger TPC 
complex, which impart NAADP+ sensitivity to TPCs. 
 
Because NAADP+ is synthesized from NADP+, it is possible that this synthesis is 
sensitive to prevailing intracellular levels of pyridine nucleotide as well as cellular 
redox state. However, CD38-ribose and ADP-ribose cyclase-dependent NAADP+ 
synthesis requires nicotinic acid, which binds to these enzyme with low affinity (half 
maximal effective concentration, 5 mmol/L).205 Therefore, under most conditions, 
the availability of nicotinic acid, rather than NADP+, is likely to be the limiting factor. 
NAADP+ signaling could, however, be coupled to the cellular redox state by 
enzymatic reduction of NAADP+ to NAADPH. NAADP+ is structurally related to 
NADP+ and it binds to NADP+-linked enzymes, such as glucose-6-phosphate 
dehydrogenase and 6-phospho gluconate dehydrogenase.215 The reduction of 
NAADP+ by glucose-6-phosphate dehydrogenase generates NAADPH, which 
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does not induce calcium release. Hence, it is possible that enzymatic reduction is 
an off signal that limits the actions of NAADP+, and that this reductive process 
couples NAADP+ signaling to the overall redox state of the cell. In this regard, it is 
interesting to point out that several processes that involve NAADP+ signaling, for 
example, fertilization,216 are also associated with dramatic changes in the redox 
state; therefore, the redox sensitivity of NAADP+ may be the missing link between 
calcium-mediated signaling and cell metabolism. 
 
Summary and Perspective 
In classical biochemistry, pyridine nucleotides are most frequently viewed 
as soluble electron carriers. As coenzymes, they are known to support oxidation–
reduction reactions and to control cell metabolism. However, recent research 
suggests that pyridine nucleotides can also regulate cell signaling, gene 
transcription, and ion transport by acting as electron donors, enzyme substrates, 
or ligands of specific receptors. Unlike most signaling molecules, pyridine 
nucleotides also impart redox sensitivity to regulatory processes. By doing so, 
these nucleotides control a large network of reactions, and therefore they can 
effectively integrate metabolism, cell signaling, gene transcription, proliferation, 
and cell death. Many of these processes depend on ion transport and homeostasis 
and, thus, the ability to regulate ion channels may be a fundamental feature of the 
biological role of pyridine nucleotides. 
Although research in this area is still maturing, several ion-transporting 
proteins have been shown to either contain NBD motifs or assemble with auxiliary 
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subunits that bind pyridine nucleotides. The association between nucleotides and 
ion transport has been conserved during evolution, and NBD-containing ion 
transport systems have been found in organisms ranging from bacterium to 
human. Although during evolution, some of these domains have been recruited to 
provide structural stability to proteins or to bind other ligands, most are still capable 
of high-affinity pyridine nucleotide binding. In addition, recent studies have shown 
that some NBD motifs of ion transport proteins are functional and that the activity 
of several ion transporters is modified by exogenous addition of pyridine 
nucleotides. There is also evidence to suggest that pyridine nucleotides regulate 
ion fluxes by binding directly to ion transport proteins or their ancillary subunits. 
Yet, there is little direct evidence showing that pyridine nucleotides are 
endogenous regulators of ion transport or that physiological or pathological 
changes in pyridine nucleotide levels have any significant effect on ion transport. 
Additional research therefore is needed to establish cause-and-effect relationships 
between pyridine nucleotides and ion transport. To delineate these relationships, 
it may be necessary to develop new methods for simultaneously measuring free 
nucleotide levels and ion transport in living cells and to determine how pyridine 
nucleotides regulate ion transport in vivo. 
As discussed, recent research has uncovered several potential 
mechanisms by which pyridine nucleotides can regulate ion fluxes. In bacterial K+ 
transporters, such as KtrA, for example, nucleotide binding induces specific 
changes in channel conformation—changes that could possibly alter the ion-
conducting properties of the channel pore.134 Similarly, in eukaryotic channels, 
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such as the Slo K+ channels, the binding of pyridine nucleotides to the cytosolic 
domain of the channel alters channel gating, whereas in Kv1 complex nucleotide 
binding to Kvβ affects inactivation of the current. In addition, as shown for Kv1164 
and SCN5A162 channels, NBD proteins could also facilitate channel trafficking and 
localization. Moreover, as in the bacterial KefC channels, catalytically active NBD 
proteins could help protect channel proteins from oxidative injury. Such proteins 
could also provide the channel privileged access to metabolites that regulate 
channel activity—as in case of the Nav-associated protein GPD1-L, which 
regulates selective PKC phosphorylation of the channel. Although the general 
applicability of this function is unclear, other channel proteins, like Kvβ, are also 
constitutively associated with PKC,72 suggesting that association with other 
signaling proteins may be required to support local channel-specific regulation. In 
most cases described in the literature, however, the speculated roles of pyridine 
nucleotides in regulating ion fluxes remain unsubstantiated. Additional research is 
required to delineate the specific roles of pyridine nucleotides and their metabolites 
in the regulation of channel activity, localization, and posttranslational modification. 
Additional research also is required to evaluate the physiological and the 
pathological implications of this regulatory axis. For instance, even though 
circumstantial evidence suggests that pyridine nucleotides play an important role 
in the regulation of HPV, insulin secretion, oxygen sensing, or even circadian 
rhythms,217 there is no clear evidence to actually implicate pyridine nucleotides in 
these phenomena. It is similarly unclear whether the ischemic dysfunction of 
myocardial ion conductances is related to changes in pyridine nucleotide signaling. 
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Finally, the exciting possibility that, in addition to being regulated by NBD proteins, 
ion transport proteins in turn can regulate the activity of pyridine nucleotide–
dependent proteins has yet to be tested. As mentioned, several channel-
associated proteins, such as KefF, Kvβ, GPD1-L, and NUDT9-H, are catalytically 
active; therefore, changes in membrane potential could affect the activities of these 
enzymes. Further exploration of this possibility could reveal new mechanisms by 
which membrane potential regulates cell chemistry and metabolism. In the brain, 
such processes might be the basic molecular units of memory and learning; in non-
neuronal cells, this mechanism could, perhaps, impart metabolic memory or 
contribute to the epigenetic regulation of gene expression. To understand these 
and other complex relationships between ion transport and pyridine nucleotides, 
however, we would first need to identify and characterize specific components of 
the individual ions channels that are regulated by pyridine nucleotides. From these 
findings, we would have to develop an integrated systemwide view—a view that 
would detail how exactly different ion transport mechanisms are synchronously 
regulated to support basic cell function or to mount a well-orchestrated unified 
response to environmental cues. Thus, further elucidation of this link between 
pyridine nucleotides and ion transport might provide a new understanding of the 
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